<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<!-- Compliance Xpressware Instance Document http://www.compliancexpressware.com/  -->
<!-- Version: 1.0.0 --><!-- Creation date:14:04:00 GMT-0700 -->
<!-- Copyright (c) Compliance Xpressware, LLP. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ltbr="http://www.ltbridge.com/20141231"  xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31">
  <link:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="ltbr-20141231.xsd"/>
  <dei:CurrentFiscalYearEndDate contextRef="cx_01_January_2014_TO_31_December_2014">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:TradingSymbol contextRef="cx_01_January_2014_TO_31_December_2014">ltbr</dei:TradingSymbol>
  <dei:EntityRegistrantName contextRef="cx_01_January_2014_TO_31_December_2014">LIGHTBRIDGE Corp</dei:EntityRegistrantName>
  <dei:DocumentPeriodEndDate contextRef="cx_01_January_2014_TO_31_December_2014">2014-12-31</dei:DocumentPeriodEndDate>
  <dei:EntityCentralIndexKey contextRef="cx_01_January_2014_TO_31_December_2014">0001084554</dei:EntityCentralIndexKey>
  <dei:EntityVoluntaryFilers contextRef="cx_01_January_2014_TO_31_December_2014">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="cx_01_January_2014_TO_31_December_2014">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="cx_01_January_2014_TO_31_December_2014">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentType contextRef="cx_01_January_2014_TO_31_December_2014">10-K</dei:DocumentType>
  <dei:AmendmentFlag contextRef="cx_01_January_2014_TO_31_December_2014">false</dei:AmendmentFlag>
  <dei:EntityCommonStockSharesOutstanding contextRef="cx_02_March_2015" unitRef="shares" decimals="INF">18082874</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityCurrentReportingStatus contextRef="cx_01_January_2014_TO_31_December_2014">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityPublicFloat contextRef="cx_30_June_2014" unitRef="usd" decimals="INF">35186138</dei:EntityPublicFloat>
  <dei:DocumentFiscalYearFocus contextRef="cx_01_January_2014_TO_31_December_2014">2014</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="cx_01_January_2014_TO_31_December_2014">FY</dei:DocumentFiscalPeriodFocus>
  <context id="cx_02_March_2015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <instant>2015-03-02</instant>
    </period>
  </context>
  <context id="cx_30_June_2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <instant>2014-06-30</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2012_StatementEquityComponentsAxis-CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2012_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2012_StatementEquityComponentsAxis-RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_StatementEquityComponentsAxis-CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_StatementEquityComponentsAxis-RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2013_StatementEquityComponentsAxis-CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2013_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2013_StatementEquityComponentsAxis-RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementEquityComponentsAxis-CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementEquityComponentsAxis-RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementEquityComponentsAxis-CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementEquityComponentsAxis-RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_RangeAxis-MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_RangeAxis-MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_RangeAxis-MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_CashAndCashEquivalentsAxis-CorporateCreditCardAndDailyAchTransactionLimitMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">ltbr:CorporateCreditCardAndDailyAchTransactionLimitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_FinancialInstrumentAxis-VanguardHighYieldCorpInvestorFundMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:VanguardHighYieldCorpInvestorFundMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_FinancialInstrumentAxis-VanguardHighYieldCorpInvestorFundMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:VanguardHighYieldCorpInvestorFundMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_MajorCustomersAxis-EnecAndFanrProjectsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">ltbr:EnecAndFanrProjectsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_MajorCustomersAxis-EnecAndFanrProjectsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">ltbr:EnecAndFanrProjectsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_MajorCustomersAxis-FanrMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">ltbr:FanrMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_MajorCustomersAxis-LloydRegisterContractMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">ltbr:LloydRegisterContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ltbr:DeferredTaxAssetAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ltbr:DeferredTaxAssetAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_01_October_2013_TO_16_October_2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-16</endDate>
    </period>
  </context>
  <context id="cx_01_October_2013_TO_16_October_2013_StatementScenarioAxis-ApproximationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-16</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_LeaseAgreementAxis-MoscowOfficeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:LeaseAgreementAxis">ltbr:MoscowOfficeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_LitigationCaseAxis-FairfaxCountyComplaintOneMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">ltbr:FairfaxCountyComplaintOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_LitigationCaseAxis-FairfaxCountyComplaintTwoMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">ltbr:FairfaxCountyComplaintTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2013_EquityTransactionAxis-IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2013_EquityTransactionAxis-IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2013_EquityTransactionAxis-IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ltbr:RangeFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2012_AwardTypeAxis-RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2011_TO_31_December_2011_AwardTypeAxis-EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_AwardTypeAxis-StockAndStockEquivalentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:StockAndStockEquivalentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_October_2013_TO_21_October_2013_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:NovemberOneTwoTwoZeroOneFourOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-21</endDate>
    </period>
  </context>
  <context id="cx_21_October_2013_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:NovemberOneTwoTwoZeroOneFourOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-21</instant>
    </period>
  </context>
  <context id="cx_21_October_2013_RangeAxis-MinimumMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:NovemberOneTwoTwoZeroOneFourOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-21</instant>
    </period>
  </context>
  <context id="cx_21_October_2013_RangeAxis-MaximumMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:NovemberOneTwoTwoZeroOneFourOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-21</instant>
    </period>
  </context>
  <context id="cx_21_October_2013_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:NovemberOneTwoTwoZeroOneFourOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-21</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:NovemberOneTwoTwoZeroOneFourOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember_AwardTypeAxis-WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:NovemberOneTwoTwoZeroOneFourOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_RangeAxis-MinimumMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_RangeAxis-MaximumMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_AwardTypeAxis-WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_July_2010_TO_22_July_2010_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-07-01</startDate>
      <endDate>2010-07-22</endDate>
    </period>
  </context>
  <context id="cx_22_July_2010_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-07-22</instant>
    </period>
  </context>
  <context id="cx_01_July_2010_TO_22_July_2010_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-07-01</startDate>
      <endDate>2010-07-22</endDate>
    </period>
  </context>
  <context id="cx_22_July_2010_RangeAxis-MinimumMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-07-22</instant>
    </period>
  </context>
  <context id="cx_22_July_2010_RangeAxis-MaximumMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:RegisteredDirectOfferingAndOutstandingWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-07-22</instant>
    </period>
  </context>
  <context id="cx_17_July_2006_AwardTypeAxis-StockCompensationPlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-07-17</instant>
    </period>
  </context>
  <context id="cx_17_July_2006_AwardTypeAxis-MaximumRestrictedSharesGrantedMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:MaximumRestrictedSharesGrantedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-07-17</instant>
    </period>
  </context>
  <context id="cx_17_July_2006_AwardTypeAxis-MaximumNumberOfSharesInRespectToStockOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:MaximumNumberOfSharesInRespectToStockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-07-17</instant>
    </period>
  </context>
  <context id="cx_17_July_2006_AwardTypeAxis-MaximumRestrictedSharesGrantedToOnePersonMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:MaximumRestrictedSharesGrantedToOnePersonMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-07-17</instant>
    </period>
  </context>
  <context id="cx_01_July_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_July_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:MayFiveTwoZeroOneFourStockOptionsGrantedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:MayFiveTwoZeroOneFourStockOptionsGrantedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfTwoFiveFiveTwoZeroTwoNonqualifiedOneZeroYearOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuanceOfTwoFiveFiveTwoZeroTwoNonqualifiedOneZeroYearOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember_RangeAxis-MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember_RangeAxis-MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-ChiefExecutiveOfficerMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-ChiefExecutiveOfficerMember_RangeAxis-MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-ChiefExecutiveOfficerMember_RangeAxis-MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-DirectorMember_RangeAxis-MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-DirectorMember_RangeAxis-MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember_RangeAxis-MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember_RangeAxis-MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ltbr:EquityTransactionAxis">ltbr:IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_AwardTypeAxis-RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_AwardTypeAxis-StockbasedCompensationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ltbr:ApproximationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:StockbasedCompensationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-ConsultingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:ConsultingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-ConsultingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:ConsultingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-TechnologyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:TechnologyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-TechnologyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:TechnologyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:CorporateAndEliminationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:CorporateAndEliminationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementBusinessSegmentsAxis-ConsultingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:ConsultingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_30_September_2013_StatementBusinessSegmentsAxis-ConsultingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:ConsultingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementBusinessSegmentsAxis-TechnologyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:TechnologyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_30_September_2013_StatementBusinessSegmentsAxis-TechnologyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:TechnologyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="cx_31_December_2014_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:CorporateAndEliminationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="cx_30_September_2013_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ltbr:CorporateAndEliminationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="cx_30_September_2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usd_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="cx_31_December_2014" unitRef="usd" decimals="0">4220225</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="cx_31_December_2013" unitRef="usd" decimals="0">3672877</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:MarketableSecuritiesCurrent contextRef="cx_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent contextRef="cx_31_December_2013" unitRef="usd" decimals="0">15731</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:RestrictedCashAndCashEquivalents contextRef="cx_31_December_2014" unitRef="usd" decimals="0">325181</us-gaap:RestrictedCashAndCashEquivalents>
  <us-gaap:RestrictedCashAndCashEquivalents contextRef="cx_31_December_2013" unitRef="usd" decimals="0">555008</us-gaap:RestrictedCashAndCashEquivalents>
  <us-gaap:AccountsReceivableNetCurrent contextRef="cx_31_December_2014" unitRef="usd" decimals="0">469086</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="cx_31_December_2013" unitRef="usd" decimals="0">425916</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:PrepaidExpenseCurrent contextRef="cx_31_December_2014" unitRef="usd" decimals="0">205184</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:PrepaidExpenseCurrent contextRef="cx_31_December_2013" unitRef="usd" decimals="0">288939</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:AssetsCurrent contextRef="cx_31_December_2014" unitRef="usd" decimals="0">5219676</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent contextRef="cx_31_December_2013" unitRef="usd" decimals="0">4958471</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="cx_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="cx_31_December_2013" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="cx_31_December_2014" unitRef="usd" decimals="0">833560</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="cx_31_December_2013" unitRef="usd" decimals="0">699168</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:Assets contextRef="cx_31_December_2014" unitRef="usd" decimals="0">6053236</us-gaap:Assets>
  <us-gaap:Assets contextRef="cx_31_December_2013" unitRef="usd" decimals="0">5657639</us-gaap:Assets>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="cx_31_December_2014" unitRef="usd" decimals="0">653668</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="cx_31_December_2013" unitRef="usd" decimals="0">476628</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:Liabilities contextRef="cx_31_December_2014" unitRef="usd" decimals="0">653668</us-gaap:Liabilities>
  <us-gaap:Liabilities contextRef="cx_31_December_2013" unitRef="usd" decimals="0">476628</us-gaap:Liabilities>
  <us-gaap:PreferredStockValue contextRef="cx_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockValue contextRef="cx_31_December_2013" unitRef="usd" decimals="0">0</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue contextRef="cx_31_December_2014" unitRef="usd" decimals="0">18083</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="cx_31_December_2013" unitRef="usd" decimals="0">15057</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital contextRef="cx_31_December_2014" unitRef="usd" decimals="0">81276339</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital contextRef="cx_31_December_2013" unitRef="usd" decimals="0">76243764</us-gaap:AdditionalPaidInCapital>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="cx_31_December_2014" unitRef="usd" decimals="0">-75894854</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="cx_31_December_2013" unitRef="usd" decimals="0">-71077810</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2014" unitRef="usd" decimals="0">5399568</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2013" unitRef="usd" decimals="0">5181011</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="cx_31_December_2014" unitRef="usd" decimals="0">6053236</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="cx_31_December_2013" unitRef="usd" decimals="0">5657639</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="cx_31_December_2014" unitRef="usd_shares" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="cx_31_December_2014" unitRef="shares" decimals="INF">50000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized contextRef="cx_31_December_2013" unitRef="shares" decimals="INF">50000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="cx_31_December_2014" unitRef="shares" xsi:nil="true"/>
  <us-gaap:PreferredStockSharesIssued contextRef="cx_31_December_2013" unitRef="shares" xsi:nil="true"/>
  <us-gaap:PreferredStockSharesOutstanding contextRef="cx_31_December_2014" unitRef="shares" xsi:nil="true"/>
  <us-gaap:PreferredStockSharesOutstanding contextRef="cx_31_December_2013" unitRef="shares" xsi:nil="true"/>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="cx_31_December_2014" unitRef="usd_shares" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="cx_31_December_2014" unitRef="shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized contextRef="cx_31_December_2013" unitRef="shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="cx_31_December_2014" unitRef="shares" decimals="INF">18082874</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="cx_31_December_2013" unitRef="shares" decimals="INF">15057243</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="cx_31_December_2014" unitRef="shares" decimals="INF">18082874</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding contextRef="cx_31_December_2013" unitRef="shares" decimals="INF">15057243</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:Revenues contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">1310199</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">1901354</us-gaap:Revenues>
  <us-gaap:CostOfRevenue contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">756277</us-gaap:CostOfRevenue>
  <us-gaap:CostOfRevenue contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">1109890</us-gaap:CostOfRevenue>
  <us-gaap:GrossProfit contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">553922</us-gaap:GrossProfit>
  <us-gaap:GrossProfit contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">791464</us-gaap:GrossProfit>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">3834935</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">3616897</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">1534605</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">2027905</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:OperatingExpenses contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">5369540</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">5644802</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-4815618</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-4853338</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestIncomeExpenseNet contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">1951</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-8133</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-3377</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-3490</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-1426</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-11623</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-4817044</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-4864961</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLoss contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-4817044</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-4864961</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="2">-0.31</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="2">-0.37</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="shares" decimals="INF">15463392</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="shares" decimals="INF">13009575</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:ShareBasedCompensation contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">282275</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">329499</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationAndAmortization contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">17221</us-gaap:DepreciationAndAmortization>
  <us-gaap:UnrealizedGainLossOnInvestments contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-1297</us-gaap:UnrealizedGainLossOnInvestments>
  <us-gaap:UnrealizedGainLossOnInvestments contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-49116</us-gaap:UnrealizedGainLossOnInvestments>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">43170</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-175887</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-83755</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-285651</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">177040</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">91405</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-4315847</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-3916182</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">14434</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">1572242</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">38880</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">134392</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">98572</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-119958</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">1434790</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">4753326</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">3958040</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-229827</us-gaap:IncreaseDecreaseInRestrictedCash>
  <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">1326</us-gaap:IncreaseDecreaseInRestrictedCash>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">4983153</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">3956714</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">547348</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">1475322</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="cx_31_December_2012" unitRef="usd" decimals="0">2197555</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaid contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:InterestPaid>
  <us-gaap:InterestPaid contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">0</us-gaap:InterestPaid>
  <us-gaap:IncomeTaxesPaid contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesPaid contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">0</us-gaap:IncomeTaxesPaid>
  <us-gaap:SharesIssued contextRef="cx_31_December_2012_StatementEquityComponentsAxis-CommonStockMember" unitRef="shares" decimals="INF">12526240</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2012_StatementEquityComponentsAxis-CommonStockMember" unitRef="usd" decimals="0">12526</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2012_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">71955631</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2012_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="usd" decimals="0">-66212849</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2012" unitRef="usd" decimals="0">5758433</us-gaap:StockholdersEquity>
  <ltbr:ProceedsFromTheSaleOfCommonStockNetOfOfferingCostsShares contextRef="cx_01_January_2013_TO_31_December_2013_StatementEquityComponentsAxis-CommonStockMember" unitRef="shares" decimals="INF">2531003</ltbr:ProceedsFromTheSaleOfCommonStockNetOfOfferingCostsShares>
  <ltbr:ProceedsFromTheSaleOfCommonStockNetOfOfferingCosts contextRef="cx_01_January_2013_TO_31_December_2013_StatementEquityComponentsAxis-CommonStockMember" unitRef="usd" decimals="0">2531</ltbr:ProceedsFromTheSaleOfCommonStockNetOfOfferingCosts>
  <ltbr:ProceedsFromTheSaleOfCommonStockNetOfOfferingCosts contextRef="cx_01_January_2013_TO_31_December_2013_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">3958634</ltbr:ProceedsFromTheSaleOfCommonStockNetOfOfferingCosts>
  <ltbr:ProceedsFromTheSaleOfCommonStockNetOfOfferingCosts contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="2">3958040.09</ltbr:ProceedsFromTheSaleOfCommonStockNetOfOfferingCosts>
  <us-gaap:NetIncomeLoss contextRef="cx_01_January_2013_TO_31_December_2013_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="usd" decimals="0">-4864961</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="cx_01_January_2013_TO_31_December_2013_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">329499</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">329499</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:SharesIssued contextRef="cx_31_December_2013_StatementEquityComponentsAxis-CommonStockMember" unitRef="shares" decimals="INF">15057243</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2013_StatementEquityComponentsAxis-CommonStockMember" unitRef="usd" decimals="0">15057</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2013_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">76243764</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2013_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="usd" decimals="0">-71077810</us-gaap:StockholdersEquity>
  <ltbr:SharesIssuedRegisteredDirectOfferingNetOfOfferingCostsShares contextRef="cx_01_January_2014_TO_31_December_2014_StatementEquityComponentsAxis-CommonStockMember" unitRef="shares" decimals="INF">3025631</ltbr:SharesIssuedRegisteredDirectOfferingNetOfOfferingCostsShares>
  <ltbr:SharesIssuedRegisteredDirectOfferingNetOfOfferingCosts contextRef="cx_01_January_2014_TO_31_December_2014_StatementEquityComponentsAxis-CommonStockMember" unitRef="usd" decimals="0">3026</ltbr:SharesIssuedRegisteredDirectOfferingNetOfOfferingCosts>
  <ltbr:SharesIssuedRegisteredDirectOfferingNetOfOfferingCosts contextRef="cx_01_January_2014_TO_31_December_2014_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">4750300</ltbr:SharesIssuedRegisteredDirectOfferingNetOfOfferingCosts>
  <ltbr:SharesIssuedRegisteredDirectOfferingNetOfOfferingCosts contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">4753326</ltbr:SharesIssuedRegisteredDirectOfferingNetOfOfferingCosts>
  <us-gaap:NetIncomeLoss contextRef="cx_01_January_2014_TO_31_December_2014_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="usd" decimals="0">-4817044</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="cx_01_January_2014_TO_31_December_2014_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">282275</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">282275</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:SharesIssued contextRef="cx_31_December_2014_StatementEquityComponentsAxis-CommonStockMember" unitRef="shares" decimals="INF">18082874</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2014_StatementEquityComponentsAxis-CommonStockMember" unitRef="usd" decimals="0">18083</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2014_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">81276339</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="cx_31_December_2014_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="usd" decimals="0">-75894854</us-gaap:StockholdersEquity>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			&lt;b&gt;Note 1. Basis of Presentation, Summary of Significant Accounting Policies, and Nature of Operations&lt;/b&gt;&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			We were formed on October 6, 2006, when Thorium Power, Ltd. merged with Thorium Power, Inc., (&amp;#8220;TPI&amp;#8221;) which had been formed in the State of Delaware on January 8, 1992. On September 29, 2009, we changed our name from Thorium Power, Ltd. to Lightbridge Corporation (&amp;#8220;Lightbridge&amp;#8221; or the &amp;#8220;Company&amp;#8221;). We are engaged in two operating business segments: our Technology Business Segment and our Consulting Business Segment (see Note 11-Business Segment Results).&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Technology Business Segment&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Our primary business segment, based on future revenue potential, is to develop innovative, proprietary nuclear fuel designs which we expect will significantly enhance the nuclear power industry&amp;#8217;s economics and increase power output by: (1) Providing an increase in power output of up to 10% while simultaneously extending the operating cycle length from 18 to 24 months in existing pressurized water reactors (which are currently limited to an 18-month operating cycle); alternatively, the power can be increased up to 17% while retaining an 18-month operating cycle; (2) Enabling increased reactor power output (up to 30% increase) without changing the core size in new build PWRs; and (3) Reducing the volume of used fuel per kilowatt-hour as well as enhancing proliferation resistance of spent fuel. There are significant technology synergies among our primary fuel products due to utilization of the proprietary metallic fuel rod technology that is at the core of each of them. Once completed, a full-scale demonstration and qualification of the metallic fuel rod technology will simultaneously advance all of our product families currently under development. Due to the significantly lower temperature during operation, our metallic nuclear fuel rods are expected to have improved safety margins during off-normal events.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			U.S. Nuclear Regulatory Commission processes require engineering analysis of a large break loss-of-coolant accident (&amp;#8220;LOCA&amp;#8221;). The scenario assumes failure of a large water pipe in the reactor coolant system. Under LOCA conditions, the fuel and cladding temperatures rise due to reduced cooling capacity. Preliminary analytical modeling shows that under a LOCA scenario, unlike conventional uranium dioxide fuel, the cladding of the Lightbridge-designed metallic fuel rods would stay at least 200 degrees below the 850-900 degrees Celsius temperature at which steam begins to react with the zirconium cladding generating hydrogen gas. Buildup of hydrogen gas in a nuclear power plant can lead to a detonation. Lightbridge fuel is designed to prevent hydrogen gas generation in LOCA situations.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			We are currently focusing our development efforts primarily on the metallic fuel with a power uprate of up to 10% and a 24-month operating cycle in existing Westinghouse-type four-loop pressurized water reactors. Those reactors represent the largest segment of our global target market. Our metallic fuel could also be adapted for use in other types of water-cooled commercial power reactors, such as boiling water reactors, CANDU heavy water reactors, as well as water-cooled small modular reactors.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			On October 20, 2014, we announced the signing of an initial cooperation agreement with Canadian Nuclear Laboratories (&amp;#8220;CNL&amp;#8221;), formerly known as Atomic Energy of Canada Limited-Chalk River Laboratories, for fabrication and test reactor irradiation of Lightbridge's patented next generation metallic nuclear fuel samples. The work will take place at CNL's facilities at Chalk River, Ontario, Canada.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Consulting Business Segment&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Our business model expanded with the establishment of a consulting business segment in 2007, through which we provide consulting and strategic advisory services to companies and governments planning to create or expand electricity generation capabilities using nuclear power plants. On August 1, 2008, we signed separate consulting services agreements with two government entities: Emirates Nuclear Energy Corporation (&amp;#8220;ENEC&amp;#8221;) formed by Abu Dhabi, one of the member Emirates of the United Arab Emirates (&amp;#8220;UAE&amp;#8221;), and the Federal Authority for Nuclear Regulation (&amp;#8220;FANR&amp;#8221;) formed by the government of the UAE. Under these two original agreements, we have provided consulting and strategic advisory services over a contract term of five years starting from June 23, 2008. The ENEC contract has been extended through 2015. The FANR contract has been extended to December 31, 2016. These contracts can each continue to be extended upon agreement by both parties.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			On October 7, 2013, we were selected as technical advisor to provide independent re-verification of equipment and material procurement processes related to construction and maintenance of nuclear power plants operated by Korea Hydro and Nuclear Power Company (&amp;#8220;KHNP&amp;#8221;). As a subcontractor to London-based Lloyd's Register Group Limited, we will focus on the environmental and seismic qualification and commercial grade dedication aspects of a two-year Lloyd's Register/KHNP contract.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			On August 11, 2014, we were selected to provide quality assurance, safety and construction and operational readiness inspection services in support of the in-house inspection team of FANR. As a team with Lloyd&amp;#8217;s Register, this work is in addition to our ongoing support of FANR&amp;#8217;s activities and is contracted to extend to December 2017.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			On August 14, 2014, we signed a Memorandum of Understanding with the Vietnam Agency for Radiation and Nuclear Safety (&amp;#8220;VARANS&amp;#8221;) to provide regulatory, legal, and administrative support to Vietnam&amp;#8217;s civil nuclear program.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			On October 17, 2014, we signed with the Vietnam Atomic Energy Institute (&amp;#8220;VINATOM&amp;#8221;) a comprehensive cooperation agreement for consulting services related to the construction and safe operation of Vietnam's Atomic Energy Research Center, including a nuclear research reactor. Our collaboration with VINATOM involves 24 specific activities, including design review and selection of nuclear research reactors, site selection, and nuclear security protocols.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			On October 17, 2014, we signed with Vietnam's leading energy engineering consultant, Power Engineering Consulting Joint Stock Company 1 (&amp;#8220;PECC1&amp;#8221;), a teaming agreement for consulting services related to construction and safe operation of a nuclear research reactor, which is planned as part of the country's Center for Nuclear Energy Science and Technology (&amp;#8220;CNEST&amp;#8221;). Work under the five-year, Lightbridge/VINATOM agreement will support CNEST, Vietnam's nuclear science and technology center, a planned $500 million facility. The VINATOM agreement also stipulates support for nuclear quality assurance; research-reactor fuel selection; control-room operations; safeguards, control and accounting of nuclear material; and related training programs.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			During the fourth quarter of 2014, we signed a contract with ENEC to provide management consulting services to their Seoul Korea office, on a time and material basis.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			&lt;b&gt;Accounting Policies and Pronouncements&lt;/b&gt;&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Basis of Consolidation&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					These consolidated financial statements include the accounts of Lightbridge, a Nevada corporation, and our wholly-owned subsidiaries, TPI, a Delaware corporation, Lightbridge International Holding LLC, a Delaware limited liability company, and our foreign branch offices.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					All significant intercompany transactions and balances have been eliminated in consolidation. We registered a branch office in the United Kingdom in 2008 called Lightbridge Advisors Limited (inactive) and we also established a branch office in Moscow, Russia, in July 2009, both of which are wholly owned by Lightbridge International Holding LLC at December 31, 2014. These branch offices will be closed in 2015. Translation gains and losses for the years ended December 31, 2014 and 2013, were not significant.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Use of Estimates and Assumptions&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Significant Estimates&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					These accompanying consolidated financial statements include some amounts that are based on management&amp;#8217;s best estimates and judgments. The most significant estimates relate to valuation of stock grants and stock options, the valuation allowance on deferred tax assets, and various contingent liabilities. It is reasonably possible that these above-mentioned estimates and others may be adjusted as more current information becomes available, and any adjustment could be significant in future reporting periods. It is also reasonably possible that the actual grant date value of the stock options vested might have been materially different than the estimated value.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Company Liquidity, Certain Risks, Uncertainties and Concentrations&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Management anticipates, based on the Company&amp;#8217;s projected working capital requirements including its projected research and development expenses over the next 12 months, that it will need to raise additional capital in 2015 by way of an offering of equity securities, an offering of debt securities, or a financing through a bank. The Company continues to reduce its current operating expenses and may also need to reduce its projected research and development expenditures in 2015 in order to maintain sufficient working capital for the next 12 months.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					We participate in a government-regulated industry. Our operating results are affected by a wide variety of factors including decreases in the use or public favor of nuclear power, the ability of our technology, the ability to safeguard the production of nuclear power, and to safeguard our patents and intellectual property from competitors. Due to these factors, we may experience substantial period-to-period fluctuations in our future operating results. Potentially, a loss of a key officer, key management, and other personnel could impair our ability to successfully execute our business strategy, particularly when these individuals have acquired specialized knowledge and skills with respect to nuclear power and our operations.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Our future operations and earnings currently depend on the results of the Company&amp;#8217;s operations outside the United States. There can be no assurance that the Company will be able to successfully continue to conduct such operations, and a failure to do so would have a material adverse effect on the Company&amp;#8217;s research and development activities, financial position, results of operations, and cash flows. Also, the success of the Company&amp;#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&amp;#8217;s control. These contingencies include general and regional economic conditions, competition, changes in regulations, changes in accounting and taxation standards, inability to achieve our overall long-term goals, future impairment charges, and global or regional catastrophic events. Because the Company is dependent on its international operations for almost all its revenue, the Company may be subject to various additional political, economic, and other uncertainties.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash equivalents and accounts receivable. Cash equivalents consist of a checking account held with one major financial institution with a high credit standing.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Accounts receivable are typically unsecured and are primarily derived from revenues earned from customers located in the Middle East. We perform ongoing evaluations to determine customer credit and we limit the amount of credit we extend, but generally we do not require collateral from our customers. We maintain reserves for estimated credit losses; however, no reserve has been set up for 2014 and 2013, as we have not incurred any credit losses from our customers to date. Substantially all of our consulting revenues were from our Middle East contracts, for the years ended December 31, 2014 and 2013, respectively.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Revenue Recognition&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Consulting Business Segment&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					At the present time, we derive all of our revenue from our consulting and strategic advisory services business segment, by offering consulting services to governments outside the United States planning to create or expand electricity generation capabilities using nuclear power plants. Our fee structure for each client engagement is dependent on a number of variables, including the size of the client, the complexity, the level of the opportunity for us to improve the client&amp;#8217;s electrical generation capabilities using nuclear power plants, and other factors. The accounting policy we use to recognize revenue depends on the terms and conditions of the specific contract.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Revenues from the Executive Affairs Authority (&amp;#8220;EAA&amp;#8221;) of Abu Dhabi, one of the member Emirates of the UAE, and the related entities, ENEC and FANR, are billed on both on a time and expense basis and on a fixed contract basis with revenue recognized based on the acceptance of defined contract deliverables.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Certain customer arrangements require evaluation of the criteria outlined in the accounting standards for reporting revenue &amp;#8220; &lt;i&gt;Gross as a Principal Versus Net as an Agent&lt;/i&gt; &amp;#8221; in determining whether it is appropriate to record the gross amount of revenue and related costs, or the net amount earned as agent fees. Generally, when we are primarily obligated in a transaction, revenue is recorded on a gross basis. Other factors that we consider in determining whether to recognize revenue on a gross versus net basis include our assumption of credit risk, latitude in establishing prices, our determination of service specifications, and our involvement in the provision of services. We have determined, based on the credit risk that we bear for collecting consulting fees, travel costs, and other reimbursable costs from our customers, that in 2014 and 2013 we acted as a principal, and therefore we are recognizing as revenue all travel costs and other reimbursable costs billed to our customers.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Cost of consulting services includes labor, travel expenses, and other related consulting costs. All costs directly related to producing work under certain consulting agreements where revenue is recognized upon acceptance of certain contractual milestones by our customer, are first capitalized as deferred project costs. Deferred project costs are then recognized or amortized to an expense captioned &amp;#8220;cost of consulting services provided&amp;#8221; on the accompanying consolidated statement of operations, when the revenue is recognized upon the delivery and acceptance of the defined contractual milestones or deliverables.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Technology Business Segment&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Once our nuclear fuel designs have advanced to a commercially usable stage by either a fuel fabricator or nuclear plant owner/operator, we will seek to license our technology to them or to major government contractors working for the U.S. or other governments. We expect that our revenue from these license fees will be recognized on a straight-line basis over the expected period of the related license term.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Stock-Based Compensation&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					The stock-based compensation expense incurred by Lightbridge for employees and directors in connection with its stock option plan is based on the employee model of ASC 718, and the fair market value of the options is measured at the grant date. Under ASC 718 employee is defined as, &amp;#8220;An individual over whom the grantor of a share-based compensation award exercises or has the right to exercise sufficient control to establish an employer-employee relationship based on common law as illustrated in case law and currently under U.S. Tax Regulations&amp;#8221;. Our advisory board members and consultants do not meet the employer-employee relationship as defined by the IRS and therefore are accounted for under ASC 505-50.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					ASC 505-50-30-11 (previously EITF 96-18) further provides that an issuer shall measure the fair value of the equity instruments in these transactions using the stock price and other measurement assumptions as of the earlier of the following dates, referred to as the measurement date:&lt;/p&gt;
				&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
					&lt;tr&gt;
						&lt;td width="5%"&gt;
							&amp;nbsp;&lt;/td&gt;
						&lt;td valign="top" width="5%"&gt;
							i.&lt;/td&gt;
						&lt;td&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;
								The date at which a commitment for performance by the counterparty to earn the equity instruments is reached (a performance commitment); and&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td width="5%"&gt;
							&amp;nbsp;&lt;/td&gt;
						&lt;td width="5%"&gt;
							&amp;nbsp;&lt;/td&gt;
						&lt;td&gt;
							&amp;nbsp;&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td width="5%"&gt;
							&amp;nbsp;&lt;/td&gt;
						&lt;td valign="top" width="5%"&gt;
							ii.&lt;/td&gt;
						&lt;td&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;
								The date at which the counterparty&amp;#8217;s performance is complete.&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					We have elected to use the Black-Scholes-Merton pricing model to determine the fair value of stock options on the measurement date of the grant. Restricted stock units are measured based on the fair market values of the underlying stock on the measurement date of the grant. Shares that are issued to officers on the exercise dates of their stock options may be issued net of the statutory withholding requirements to be paid by us on behalf of our employees. As a result, the actual number of shares issued will be fewer than the actual number of shares exercised under the stock option. We recognize stock-based compensation using the straight-line method.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					For each of the years ended December 31, 2014 and 2013, we recognized stock-based compensation of approximately $0.3 million. Related income tax benefits were not recognized, as we incurred a tax loss for both years.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Fair Value of Financial Instruments&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					The carrying amounts of our financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities. We carry marketable securities at fair value. All marketable securities were sold in 2014.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Cash and Cash Equivalents, Restricted Cash and Marketable Securities&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					We invest our excess cash in money market mutual funds, and mutual bond funds. We classify all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months as marketable securities. We hold cash balances in excess of the federally insured limits of $250,000 with one prominent financial institution. We deem this credit risk not to be significant as our cash is held by a major prominent financial institution. Total cash and cash equivalents held in checking accounts and a money market core cash account, as reported on the accompanying consolidated balance sheets, totaled approximately $4.2 million and $3.7 million at December 31, 2014 and 2013, respectively.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Restricted cash represents cash being held by one prominent financial institution that is being used as collateral for our corporate credit cards and future letters of credit that we may issue to some of our foreign customers. The total balance of our restricted cash at December 31, 2014 and 2013 was approximately $0.3 million and $0.6 million, respectively.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Currently $30,000 of the restricted cash is dedicated to our corporate credit card and daily ACH transaction limit. The balance of the restricted cash is for future letters of credit. There were no Letters of Credit outstanding at December 31, 2014 and 2013. We are free to lower the amount of cash held in the restricted account if we decide to discontinue this arrangement with our Financial Institution.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					We determine the appropriate classification of our investments in marketable securities at the time of purchase and reevaluate such designation at each balance sheet date. We have classified and accounted for our marketable securities as available-for-sale, however we carry these securities at fair value (see below election made to value these financial instruments at fair market value). The fair value of substantially all securities is determined by quoted market prices.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					All marketable securities are classified as available-for-sale securities and are reported at their fair value (level 1). A level 1 measurement under the FASB pronouncements is the first tier of a three tier hierarchy for fair value measurements used in valuation methodologies. This valuation level allows for fair value measurements where the inputs are the quoted prices for the assets in the active markets. All of our marketable securities have quoted market prices and these quoted prices are used to determine the fair value of our marketable securities.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					The total quoted fair value of our marketable securities at December 31, 2014 and December 31, 2013, was approximately $0 and $16,000, respectively. This amount was held in Vanguard High Yield Corp Investor Fund (Symbol -VWEHX). The cost basis of this above investment at December 31, 2013, was approximately $15,000.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Investment Income (loss) is earned on marketable securities and consists of unrealized gains (losses), realized capital gains or losses, interest and dividends received, as reported to us from the financial institutions in which they were reinvested, and totaled approximately $2,000 and ($8,000) for the years ended December 31, 2014 and 2013, respectively. We elected the fair value option permitted under FASB ASC 825 to report the unrealized gains and losses from our marketable securities in our accompanying consolidated statement of operations instead of other comprehensive income and loss. Management believes the fair value option provides a better indication of the Company&amp;#8217;s performance.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Trade Accounts Receivable&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					We record accounts receivable at the invoiced amount and we do not charge interest. We review the accounts receivable by amounts due from customers which are past due, to identify specific customers with known disputes or collectability issues. In determining the amount of the reserve, we make judgments about the creditworthiness of significant customers based on ongoing credit evaluations. We will also maintain a sales allowance to reserve for potential credits issued to customers. We will determine the amount of the reserve based on historical credits issued.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					There was no provision for doubtful accounts recorded at December 31, 2014 and 2013, as we have not experienced any significant bad debt write-offs from any of our customers. Substantially all accounts receivable at December 31, 2014 and 2013 are from the FANR and ENEC contracts (see Note 3-Accounts Receivable &amp;#8211; Project Revenue and Reimbursable Project Costs).&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Income Taxes&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Income taxes are accounted for under the asset and liability method in accordance with United States generally accepted accounting principles. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial carrying amounts of existing assets and liabilities and their respective tax bases as well as operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the extent that the recoverability of the asset is unlikely to be recognized. We did not provide any current or deferred income tax provision or benefit for any periods presented to date because we have continued to experience a net operating loss since inception and therefore provide a 100% valuation allowance against all of our deferred tax assets (see Note 7&amp;#8211;Income Taxes).&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					The Company adopted the ASC accounting pronouncement &amp;#8220; &lt;i&gt;Accounting for Uncertainty in Income Taxes&lt;/i&gt; &amp;#8221;. This pronouncement provides guidance for recognizing and measuring uncertain tax positions, as defined in the FASB accounting pronouncement &amp;#8220; &lt;i&gt;Accounting for Income Taxes&lt;/i&gt; &amp;#8221;. This pronouncement prescribes a threshold condition that a tax position must meet for any of the benefits of the uncertain tax position to be recognized in the financial statements. This pronouncement also provides accounting guidance on derecognizing, classification and disclosure of these uncertain tax positions. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company has not recognized any interest and penalties in 2014 or 2013.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Foreign Currency&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					The functional currency of our international subsidiaries and branches is the local currency. We translate the financial statements of these subsidiaries to U.S. dollars using month-end rates of exchange for assets and liabilities, and average rates of exchange for revenues, costs, and expenses. The translation gains/losses for our branch office in Russia were not significant for the years ended December 31, 2014 and 2013.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Patents and Legal Costs&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Patents are stated on the accompanying consolidated balance sheets at cost less accumulated amortization. The costs of the patents, once placed in service, will be amortized on a straight-line basis over their estimated useful lives or the remaining legal lives of the patents, whichever is shorter. The amortization periods for our patents can range between 17 and 20 years if placed into service at the beginning of their legal lives. Our patents have not been placed in service for the years ended December 31, 2014 and 2013.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Legal costs are expensed as incurred except for legal costs to file for patent extensions and protection, which are capitalized and reported as patents on the accompanying consolidated balance sheets.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Impairment of long-lived assets&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Long-lived assets of the Company are reviewed for impairment whenever events or circumstances indicate that the carrying amount of assets may not be recoverable. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset&amp;#8217;s estimated fair value and its book value. The Company did not consider it necessary to record any impairment charges for the years ended December 31, 2014 and 2013.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Research, Development and Related Expenses&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					These costs from our Technology business segment are charged to operations in the year incurred and are shown on a separate line on the accompanying Consolidated Statements of Operations. Research and development and related expenses totaled approximately $1.5 million and $2.0 million for the years ended December 31, 2014 and 2013, respectively.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Segment Reporting&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					We use the &amp;#8220;management approach&amp;#8221; in determining reportable operating segments. The management approach considers the internal organization and reporting used by our chief decision makers for making operating decisions and assessing performance, as the source for determining our reportable segments. We have determined that we have two operating segments as defined by the FASB accounting pronouncement, &amp;#8220; &lt;i&gt;Disclosures about Segments of an Enterprise and Related&lt;/i&gt; &lt;i&gt;Information&lt;/i&gt; &amp;#8221;. As discussed above, our two reporting business segments are our technology business and our consulting services business (See Note 11-Business Segment Results).&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Commitments and Contingencies&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&amp;#8217;s consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. The Company&amp;#8217;s legal costs associated with contingent liabilities are recorded to expense as incurred.&lt;/p&gt;
							&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					Recent Accounting Pronouncements&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					In May 2014, the FASB issued guidance on revenue from contracts with customers that will supersede most current revenue recognition guidance, including industry-specific guidance. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Other major provisions include capitalization of certain contract costs, consideration of time value of money in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity&amp;#8217;s contracts with customers. The guidance is effective for the interim and annual periods beginning on or after December 15, 2016, (early adoption is not permitted). The guidance permits the use of either a retrospective or cumulative effect transition method.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
					The Company does not expect the adoption of any recent accounting pronouncements to have a material impact on its financial statements.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <ltbr:BasisOfConsolidationPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Basis of Consolidation&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;These consolidated financial statements include the accounts of Lightbridge, a Nevada corporation, and our wholly-owned subsidiaries, TPI, a Delaware corporation, Lightbridge International Holding LLC, a Delaware limited liability company, and our foreign branch offices.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;All significant intercompany transactions and balances have been eliminated in consolidation. We registered a branch office in the United Kingdom in 2008 called Lightbridge Advisors Limited (inactive) and we also established a branch office in Moscow, Russia, in July 2009, both of which are wholly owned by Lightbridge International Holding LLC at December 31, 2014. These branch offices will be closed in 2015. Translation gains and losses for the years ended December 31, 2014 and 2013, were not significant.&lt;/p&gt;</ltbr:BasisOfConsolidationPolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Use of Estimates and Assumptions&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
  <ltbr:SignificantEstimatesPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Significant Estimates&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;These accompanying consolidated financial statements include some amounts that are based on management&amp;#8217;s best estimates and judgments. The most significant estimates relate to valuation of stock grants and stock options, the valuation allowance on deferred tax assets, and various contingent liabilities. It is reasonably possible that these above-mentioned estimates and others may be adjusted as more current information becomes available, and any adjustment could be significant in future reporting periods. It is also reasonably possible that the actual grant date value of the stock options vested might have been materially different than the estimated value.&lt;/p&gt;</ltbr:SignificantEstimatesPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Company Liquidity, Certain Risks, Uncertainties and Concentrations&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Management anticipates, based on the Company&amp;#8217;s projected working capital requirements including its projected research and development expenses over the next 12 months, that it will need to raise additional capital in 2015 by way of an offering of equity securities, an offering of debt securities, or a financing through a bank. The Company continues to reduce its current operating expenses and may also need to reduce its projected research and development expenditures in 2015 in order to maintain sufficient working capital for the next 12 months.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;We participate in a government-regulated industry. Our operating results are affected by a wide variety of factors including decreases in the use or public favor of nuclear power, the ability of our technology, the ability to safeguard the production of nuclear power, and to safeguard our patents and intellectual property from competitors. Due to these factors, we may experience substantial period-to-period fluctuations in our future operating results. Potentially, a loss of a key officer, key management, and other personnel could impair our ability to successfully execute our business strategy, particularly when these individuals have acquired specialized knowledge and skills with respect to nuclear power and our operations.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Our future operations and earnings currently depend on the results of the Company&amp;#8217;s operations outside the United States. There can be no assurance that the Company will be able to successfully continue to conduct such operations, and a failure to do so would have a material adverse effect on the Company&amp;#8217;s research and development activities, financial position, results of operations, and cash flows. Also, the success of the Company&amp;#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&amp;#8217;s control. These contingencies include general and regional economic conditions, competition, changes in regulations, changes in accounting and taxation standards, inability to achieve our overall long-term goals, future impairment charges, and global or regional catastrophic events. Because the Company is dependent on its international operations for almost all its revenue, the Company may be subject to various additional political, economic, and other uncertainties.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash equivalents and accounts receivable. Cash equivalents consist of a checking account held with one major financial institution with a high credit standing.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Accounts receivable are typically unsecured and are primarily derived from revenues earned from customers located in the Middle East. We perform ongoing evaluations to determine customer credit and we limit the amount of credit we extend, but generally we do not require collateral from our customers. We maintain reserves for estimated credit losses; however, no reserve has been set up for 2014 and 2013, as we have not incurred any credit losses from our customers to date. Substantially all of our consulting revenues were from our Middle East contracts, for the years ended December 31, 2014 and 2013, respectively.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <ltbr:ConsultingBusinessSegmentPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Consulting Business Segment&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;At the present time, we derive all of our revenue from our consulting and strategic advisory services business segment, by offering consulting services to governments outside the United States planning to create or expand electricity generation capabilities using nuclear power plants. Our fee structure for each client engagement is dependent on a number of variables, including the size of the client, the complexity, the level of the opportunity for us to improve the client&amp;#8217;s electrical generation capabilities using nuclear power plants, and other factors. The accounting policy we use to recognize revenue depends on the terms and conditions of the specific contract.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Revenues from the Executive Affairs Authority (&amp;#8220;EAA&amp;#8221;) of Abu Dhabi, one of the member Emirates of the UAE, and the related entities, ENEC and FANR, are billed on both on a time and expense basis and on a fixed contract basis with revenue recognized based on the acceptance of defined contract deliverables.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    Certain customer arrangements require evaluation of the criteria outlined in the accounting standards for reporting revenue &amp;#8220;
    &lt;i&gt;Gross as a Principal Versus Net as an Agent&lt;/i&gt;
    &amp;#8221; in determining whether it is appropriate to record the gross amount of revenue and related costs, or the net amount earned as agent fees. Generally, when we are primarily obligated in a transaction, revenue is recorded on a gross basis. Other factors that we consider in determining whether to recognize revenue on a gross versus net basis include our assumption of credit risk, latitude in establishing prices, our determination of service specifications, and our involvement in the provision of services. We have determined, based on the credit risk that we bear for collecting consulting fees, travel costs, and other reimbursable costs from our customers, that in 2014 and 2013 we acted as a principal, and therefore we are recognizing as revenue all travel costs and other reimbursable costs billed to our customers.
  &lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Cost of consulting services includes labor, travel expenses, and other related consulting costs. All costs directly related to producing work under certain consulting agreements where revenue is recognized upon acceptance of certain contractual milestones by our customer, are first capitalized as deferred project costs. Deferred project costs are then recognized or amortized to an expense captioned &amp;#8220;cost of consulting services provided&amp;#8221; on the accompanying consolidated statement of operations, when the revenue is recognized upon the delivery and acceptance of the defined contractual milestones or deliverables.&lt;/p&gt;</ltbr:ConsultingBusinessSegmentPolicyTextBlock>
  <ltbr:TechnologyBusinessSegmentPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Technology Business Segment&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Once our nuclear fuel designs have advanced to a commercially usable stage by either a fuel fabricator or nuclear plant owner/operator, we will seek to license our technology to them or to major government contractors working for the U.S. or other governments. We expect that our revenue from these license fees will be recognized on a straight-line basis over the expected period of the related license term.&lt;/p&gt;</ltbr:TechnologyBusinessSegmentPolicyTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Stock-Based Compensation&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The stock-based compensation expense incurred by Lightbridge for employees and directors in connection with its stock option plan is based on the employee model of ASC 718, and the fair market value of the options is measured at the grant date. Under ASC 718 employee is defined as, &amp;#8220;An individual over whom the grantor of a share-based compensation award exercises or has the right to exercise sufficient control to establish an employer-employee relationship based on common law as illustrated in case law and currently under U.S. Tax Regulations&amp;#8221;. Our advisory board members and consultants do not meet the employer-employee relationship as defined by the IRS and therefore are accounted for under ASC 505-50.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;ASC 505-50-30-11 (previously EITF 96-18) further provides that an issuer shall measure the fair value of the equity instruments in these transactions using the stock price and other measurement assumptions as of the earlier of the following dates, referred to as the measurement date:&lt;/p&gt;
  &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
    &lt;tr&gt;
      &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
      &lt;td valign="top" width="5%"&gt;i.&lt;/td&gt;
      &lt;td&gt;
        &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;The date at which a commitment for performance by the counterparty to earn the equity instruments is reached (a performance commitment); and&lt;/p&gt;
      &lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
      &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
      &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
      &lt;td valign="top" width="5%"&gt;ii.&lt;/td&gt;
      &lt;td&gt;
        &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;The date at which the counterparty&amp;#8217;s performance is complete.&lt;/p&gt;
      &lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;We have elected to use the Black-Scholes-Merton pricing model to determine the fair value of stock options on the measurement date of the grant. Restricted stock units are measured based on the fair market values of the underlying stock on the measurement date of the grant. Shares that are issued to officers on the exercise dates of their stock options may be issued net of the statutory withholding requirements to be paid by us on behalf of our employees. As a result, the actual number of shares issued will be fewer than the actual number of shares exercised under the stock option. We recognize stock-based compensation using the straight-line method.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    For each of the years ended December 31, 2014 and 2013, we recognized stock-based compensation of approximately $0.3
    million. Related income tax benefits were not recognized, as we incurred a tax loss for both years.
  &lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The carrying amounts of our financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities. We carry marketable securities at fair value. All marketable securities were sold in 2014.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Cash and Cash Equivalents, Restricted Cash and Marketable Securities&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    We invest our excess cash in money market mutual funds, and mutual bond funds. We classify all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months as marketable securities. We hold cash balances in excess of the federally insured limits of $250,000
    with one prominent financial institution. We deem this credit risk not to be significant as our cash is held by a major prominent financial institution. Total cash and cash equivalents held in checking accounts and a money market core cash account, as reported on the accompanying consolidated balance sheets, totaled approximately $4.2
    million and $3.7
    million at December 31, 2014 and 2013, respectively.
  &lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    Restricted cash represents cash being held by one prominent financial institution that is being used as collateral for our corporate credit cards and future letters of credit that we may issue to some of our foreign customers. The total balance of our restricted cash at December 31, 2014 and 2013 was approximately $0.3
    million and $0.6
    million, respectively.
  &lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    Currently $30,000
    of the restricted cash is dedicated to our corporate credit card and daily ACH transaction limit. The balance of the restricted cash is for future letters of credit. There were no Letters of Credit outstanding at December 31, 2014 and 2013. We are free to lower the amount of cash held in the restricted account if we decide to discontinue this arrangement with our Financial Institution.
  &lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;We determine the appropriate classification of our investments in marketable securities at the time of purchase and reevaluate such designation at each balance sheet date. We have classified and accounted for our marketable securities as available-for-sale, however we carry these securities at fair value (see below election made to value these financial instruments at fair market value). The fair value of substantially all securities is determined by quoted market prices.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;All marketable securities are classified as available-for-sale securities and are reported at their fair value (level 1). A level 1 measurement under the FASB pronouncements is the first tier of a three tier hierarchy for fair value measurements used in valuation methodologies. This valuation level allows for fair value measurements where the inputs are the quoted prices for the assets in the active markets. All of our marketable securities have quoted market prices and these quoted prices are used to determine the fair value of our marketable securities.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    The total quoted fair value of our marketable securities at December 31, 2014 and December 31, 2013, was approximately $0
    and $16,000, respectively. This amount was held in Vanguard High Yield Corp Investor Fund (Symbol -VWEHX). The cost basis of this above investment at December 31, 2013, was approximately $15,000.
  &lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    Investment Income (loss) is earned on marketable securities and consists of unrealized gains (losses), realized capital gains or losses, interest and dividends received, as reported to us from the financial institutions in which they were reinvested, and totaled approximately $2,000
    and ($8,000) for the years ended December 31, 2014 and 2013, respectively. We elected the fair value option permitted under FASB ASC 825 to report the unrealized gains and losses from our marketable securities in our accompanying consolidated statement of operations instead of other comprehensive income and loss. Management believes the fair value option provides a better indication of the Company&amp;#8217;s performance.
  &lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Trade Accounts Receivable&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;We record accounts receivable at the invoiced amount and we do not charge interest. We review the accounts receivable by amounts due from customers which are past due, to identify specific customers with known disputes or collectability issues. In determining the amount of the reserve, we make judgments about the creditworthiness of significant customers based on ongoing credit evaluations. We will also maintain a sales allowance to reserve for potential credits issued to customers. We will determine the amount of the reserve based on historical credits issued.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;There was no provision for doubtful accounts recorded at December 31, 2014 and 2013, as we have not experienced any significant bad debt write-offs from any of our customers. Substantially all accounts receivable at December 31, 2014 and 2013 are from the FANR and ENEC contracts (see Note 3-Accounts Receivable &amp;#8211; Project Revenue and Reimbursable Project Costs).&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Income Taxes&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    Income taxes are accounted for under the asset and liability method in accordance with United States generally accepted accounting principles. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial carrying amounts of existing assets and liabilities and their respective tax bases as well as operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the extent that the recoverability of the asset is unlikely to be recognized. We did not provide any current or deferred income tax provision or benefit for any periods presented to date because we have continued to experience a net operating loss since inception and therefore provide a
    100% valuation allowance against all of our deferred tax assets (see Note 7&amp;#8211;Income Taxes).
  &lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    The Company adopted the ASC accounting pronouncement &amp;#8220;
    &lt;i&gt;Accounting for Uncertainty in Income Taxes&lt;/i&gt;
    &amp;#8221;. This pronouncement provides guidance for recognizing and measuring uncertain tax positions, as defined in the FASB accounting pronouncement &amp;#8220;
    &lt;i&gt;Accounting for Income Taxes&lt;/i&gt;
    &amp;#8221;. This pronouncement prescribes a threshold condition that a tax position must meet for any of the benefits of the uncertain tax position to be recognized in the financial statements. This pronouncement also provides accounting guidance on derecognizing, classification and disclosure of these uncertain tax positions. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company has not recognized any interest and penalties in 2014 or 2013.
  &lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Foreign Currency&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The functional currency of our international subsidiaries and branches is the local currency. We translate the financial statements of these subsidiaries to U.S. dollars using month-end rates of exchange for assets and liabilities, and average rates of exchange for revenues, costs, and expenses. The translation gains/losses for our branch office in Russia were not significant for the years ended December 31, 2014 and 2013.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
  <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Patents and Legal Costs&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    Patents are stated on the accompanying consolidated balance sheets at cost less accumulated amortization. The costs of the patents, once placed in service, will be amortized on a straight-line basis over their estimated useful lives or the remaining legal lives of the patents, whichever is shorter. The amortization periods for our patents can range between
    17
    and
    20
    years if placed into service at the beginning of their legal lives. Our patents have not been placed in service for the years ended December 31, 2014 and 2013.
  &lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Legal costs are expensed as incurred except for legal costs to file for patent extensions and protection, which are capitalized and reported as patents on the accompanying consolidated balance sheets.&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Impairment of long-lived assets&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Long-lived assets of the Company are reviewed for impairment whenever events or circumstances indicate that the carrying amount of assets may not be recoverable. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset&amp;#8217;s estimated fair value and its book value. The Company did not consider it necessary to record any impairment charges for the years ended December 31, 2014 and 2013.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Research, Development and Related Expenses&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    These costs from our Technology business segment are charged to operations in the year incurred and are shown on a separate line on the accompanying Consolidated Statements of Operations. Research and development and related expenses totaled approximately $1.5
    million and $2.0
    million for the years ended December 31, 2014 and 2013, respectively.
  &lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Segment Reporting&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
    We use the &amp;#8220;management approach&amp;#8221; in determining reportable operating segments. The management approach considers the internal organization and reporting used by our chief decision makers for making operating decisions and assessing performance, as the source for determining our reportable segments. We have determined that we have two operating segments as defined by the FASB accounting pronouncement, &amp;#8220;
    &lt;i&gt;Disclosures about Segments of an Enterprise and Related&lt;/i&gt;
    &lt;i&gt;Information&lt;/i&gt;
    &amp;#8221;. As discussed above, our two reporting business segments are our technology business and our consulting services business (See Note 11-Business Segment Results).
  &lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
  <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Commitments and Contingencies&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&amp;#8217;s consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. The Company&amp;#8217;s legal costs associated with contingent liabilities are recorded to expense as incurred.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;In May 2014, the FASB issued guidance on revenue from contracts with customers that will supersede most current revenue recognition guidance, including industry-specific guidance. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Other major provisions include capitalization of certain contract costs, consideration of time value of money in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity&amp;#8217;s contracts with customers. The guidance is effective for the interim and annual periods beginning on or after December 15, 2016, (early adoption is not permitted). The guidance permits the use of either a retrospective or cumulative effect transition method.&lt;/p&gt;
  &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The Company does not expect the adoption of any recent accounting pronouncements to have a material impact on its financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <ltbr:PowerOutputIncreaseBasedOnFuturePotentialReveunes contextRef="cx_01_January_2014_TO_31_December_2014_RangeAxis-MinimumMember" unitRef="pure" decimals="2">0.10</ltbr:PowerOutputIncreaseBasedOnFuturePotentialReveunes>
  <ltbr:OperatingCycleLength contextRef="cx_01_January_2014_TO_31_December_2014">P18M</ltbr:OperatingCycleLength>
  <ltbr:ExtentionOfFuelCycleLength contextRef="cx_01_January_2014_TO_31_December_2014">P24M</ltbr:ExtentionOfFuelCycleLength>
  <ltbr:PowerOutputIncreaseBasedOnFuturePotentialReveunes contextRef="cx_01_January_2014_TO_31_December_2014_RangeAxis-MaximumMember" unitRef="pure" decimals="2">0.17</ltbr:PowerOutputIncreaseBasedOnFuturePotentialReveunes>
  <ltbr:MaximumIncreaseInPowerOutputBasedOnFutureRevenue contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="pure" decimals="2">0.30</ltbr:MaximumIncreaseInPowerOutputBasedOnFutureRevenue>
  <ltbr:MetallicFuelPowerUpratePercentage contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="pure" decimals="2">0.10</ltbr:MetallicFuelPowerUpratePercentage>
  <ltbr:OperatingCycleLengthWestinghouseType contextRef="cx_01_January_2014_TO_31_December_2014">P24M</ltbr:OperatingCycleLengthWestinghouseType>
  <ltbr:ValueOfNuclearScienceAndTechnologyCentre contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="-6">500000000</ltbr:ValueOfNuclearScienceAndTechnologyCentre>
  <us-gaap:ShareBasedCompensation contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">300000</us-gaap:ShareBasedCompensation>
  <us-gaap:CashFDICInsuredAmount contextRef="cx_31_December_2014_RangeAxis-MaximumMember" unitRef="usd" decimals="0">250000</us-gaap:CashFDICInsuredAmount>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">4200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">3700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestrictedCashAndInvestments contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">300000</us-gaap:RestrictedCashAndInvestments>
  <us-gaap:RestrictedCashAndInvestments contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">600000</us-gaap:RestrictedCashAndInvestments>
  <us-gaap:RestrictedCashAndInvestments contextRef="cx_31_December_2014_CashAndCashEquivalentsAxis-CorporateCreditCardAndDailyAchTransactionLimitMember" unitRef="usd" decimals="0">30000</us-gaap:RestrictedCashAndInvestments>
  <us-gaap:MarketableSecurities contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_FinancialInstrumentAxis-VanguardHighYieldCorpInvestorFundMember" unitRef="usd" decimals="0">0</us-gaap:MarketableSecurities>
  <us-gaap:MarketableSecurities contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_FinancialInstrumentAxis-VanguardHighYieldCorpInvestorFundMember" unitRef="usd" decimals="0">16000</us-gaap:MarketableSecurities>
  <us-gaap:OtherInvestmentsAndSecuritiesAtCost contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_FinancialInstrumentAxis-VanguardHighYieldCorpInvestorFundMember" unitRef="usd" decimals="0">15000</us-gaap:OtherInvestmentsAndSecuritiesAtCost>
  <ltbr:UnrealizedGainLossFromFinancialInstitutions contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">2000</ltbr:UnrealizedGainLossFromFinancialInstitutions>
  <ltbr:UnrealizedGainLossFromFinancialInstitutions contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">8000</ltbr:UnrealizedGainLossFromFinancialInstitutions>
  <ltbr:ValuationAllowance contextRef="cx_31_December_2014" unitRef="pure" decimals="2">1.00</ltbr:ValuationAllowance>
  <ltbr:ValuationAllowance contextRef="cx_31_December_2012" unitRef="pure" decimals="2">1.00</ltbr:ValuationAllowance>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="cx_01_January_2014_TO_31_December_2014_RangeAxis-MinimumMember">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="cx_01_January_2014_TO_31_December_2014_RangeAxis-MaximumMember">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">1500000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">2000000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:EarningsPerShareTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 2. Net Loss Per Share&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Basic net loss per share is computed using the weighted-average number of common shares outstanding during the period except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, warrants, restricted shares, and unvested common shares subject to repurchase or cancellation. The dilutive effect of outstanding stock options, restricted shares, restricted stock units, and warrants is not reflected in diluted earnings per share because we incurred net losses for the years ended December 31, 2014 and 2013, and the effect of including these potential common shares in the diluted earnings per share calculations would be anti-dilutive and are therefore not included in the calculations.&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The following table sets forth the computation of the basic and diluted loss per share (in millions except shares and per share amounts):&lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
          &lt;tr valign="top"&gt;
            &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2014&lt;/td&gt;
            &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2013&lt;/td&gt;
            &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr valign="top"&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Numerator:&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr valign="top"&gt;
            &lt;td align="left" valign="bottom"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160;Net loss&lt;/td&gt;
            &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
            &lt;td align="right" valign="bottom" width="12%"&gt;
              (4.8
            &lt;/td&gt;
            &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
            &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
            &lt;td align="right" valign="bottom" width="12%"&gt;
              (4.9
            &lt;/td&gt;
            &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr valign="top"&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Denominator:&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr valign="top"&gt;
            &lt;td align="left" valign="bottom"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160;Weighted-average common shares outstanding&lt;/td&gt;
            &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="right" valign="bottom" width="12%"&gt;
              15,463,392
            &lt;/td&gt;
            &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
            &lt;td align="right" valign="bottom" width="12%"&gt;
              13,009,575
            &lt;/td&gt;
            &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr valign="top"&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160;Basic and diluted net loss per share&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
            &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
              (0.31
            &lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
            &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
              (0.37
            &lt;/td&gt;
            &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
      &lt;tr valign="top"&gt;
        &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2014&lt;/td&gt;
        &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2013&lt;/td&gt;
        &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr valign="top"&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Numerator:&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr valign="top"&gt;
        &lt;td align="left" valign="bottom"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160;Net loss&lt;/td&gt;
        &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
        &lt;td align="right" valign="bottom" width="12%"&gt;
          (4.8
        &lt;/td&gt;
        &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
        &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
        &lt;td align="right" valign="bottom" width="12%"&gt;
          (4.9
        &lt;/td&gt;
        &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr valign="top"&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Denominator:&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr valign="top"&gt;
        &lt;td align="left" valign="bottom"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160;Weighted-average common shares outstanding&lt;/td&gt;
        &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="right" valign="bottom" width="12%"&gt;
          15,463,392
        &lt;/td&gt;
        &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
        &lt;td align="right" valign="bottom" width="12%"&gt;
          13,009,575
        &lt;/td&gt;
        &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr valign="top"&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160;Basic and diluted net loss per share&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
        &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
          (0.31
        &lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
        &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
          (0.37
        &lt;/td&gt;
        &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:NetIncomeLoss contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">-4800000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">-4900000</us-gaap:NetIncomeLoss>
  <us-gaap:OtherAssetsDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 3. Accounts Receivable &amp;#8211; Project Revenue and Reimbursable Project Costs&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;FANR and ENEC Projects&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      The total accounts receivable from the FANR and ENEC contracts was approximately $0.5
      and $0.4
      million at December 31, 2014 and 2013, respectively. These amounts due from FANR and ENEC represent approximately
      92% of the total accounts receivable reported at December 31, 2014. Approximately
      81% and
      95% of the total revenues reported for the years ended December 31, 2014 and 2013, were from the FANR and ENEC contracts. Approximately
      15% of the total revenues for the year ended December 31, 2014 was from the Lloyd&amp;#8217;s Register contract.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      Total unbilled accounts receivable included in the accompanying consolidated balance sheets and reported in accounts receivable of approximately $40,000
      and $100,000
      at December 31, 2014 and 2013, and is for work that was billed to our clients in January 2015 and January 2014, respectively. Foreign currency transaction exchange losses and translation gains and losses for the year ended December, 2014 and 2013, were not significant.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      Travel costs and other reimbursable costs under these contracts are reported in the accompanying statement of operations as both revenue and cost of consulting services provided, and totaled approximately $0.1
      million for the years ended December 31, 2014 and 2013, respectively. The total travel and other reimbursable expenses that have not been reimbursed to us and are included in total accounts receivable reported above from our consulting contracts was not significant at December 31, 2014 and 2013.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Under these agreements, revenue will be recognized on a time and expense basis and fixed contract basis with revenue recognized upon the completion of contract milestones and acceptance by the client. We periodically discuss our consulting work with ENEC and FANR, who will review the work we perform, and our reimbursable travel expenses, and accept our monthly invoicing for services and reimbursable expenses. We expect the variation of revenue we earn from these contracts to continue.&lt;/p&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
  <us-gaap:AccountsReceivableNet contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_MajorCustomersAxis-EnecAndFanrProjectsMember" unitRef="usd" decimals="-5">500000</us-gaap:AccountsReceivableNet>
  <us-gaap:AccountsReceivableNet contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_MajorCustomersAxis-EnecAndFanrProjectsMember" unitRef="usd" decimals="-5">400000</us-gaap:AccountsReceivableNet>
  <ltbr:MajorCustomerRevenuePercentage contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_MajorCustomersAxis-FanrMember" unitRef="pure" decimals="2">0.92</ltbr:MajorCustomerRevenuePercentage>
  <ltbr:MajorCustomerRevenuePercentage contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_MajorCustomersAxis-EnecAndFanrProjectsMember" unitRef="pure" decimals="2">0.81</ltbr:MajorCustomerRevenuePercentage>
  <ltbr:MajorCustomerRevenuePercentage contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_MajorCustomersAxis-EnecAndFanrProjectsMember" unitRef="pure" decimals="2">0.95</ltbr:MajorCustomerRevenuePercentage>
  <ltbr:MajorCustomerRevenuePercentage contextRef="cx_31_December_2014_MajorCustomersAxis-LloydRegisterContractMember" unitRef="pure" decimals="2">0.15</ltbr:MajorCustomerRevenuePercentage>
  <us-gaap:UnbilledContractsReceivable contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">40000</us-gaap:UnbilledContractsReceivable>
  <us-gaap:UnbilledContractsReceivable contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">100000</us-gaap:UnbilledContractsReceivable>
  <us-gaap:TravelAndEntertainmentExpense contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">100000</us-gaap:TravelAndEntertainmentExpense>
  <us-gaap:TravelAndEntertainmentExpense contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">100000</us-gaap:TravelAndEntertainmentExpense>
  <ltbr:PrepaidExpensesOtherCurrentAssetsTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 4. Prepaid Expenses &amp;amp; Other Current Assets&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      Prepaid expenses consist primarily of prepayments made for various insurance policies, travel, rent, and other miscellaneous prepayments. Total prepaid expenses and other current assets reported on the accompanying consolidated balance sheets at December 31, 2014 and 2013, were approximately $0.2
      million and $0.3
      million, respectively.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      One month of rent or approximately $30,000
      represents the security deposit placed on the McLean, Virginia corporate offices. The security deposit at December 31, 2014 and 2013, is reported under the balance sheet caption prepaid expenses and other current assets.
    &lt;/p&gt;</ltbr:PrepaidExpensesOtherCurrentAssetsTextBlock>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">200000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">300000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:SecurityDeposit contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">30000</us-gaap:SecurityDeposit>
  <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 5. Patents and Other Assets&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      Patents represent legal fees and filing costs that are capitalized and amortized over their estimated useful lives of
      17
      to
      20
      years or their remaining legal lives, whichever is shorter, after they are placed in service. There were no patents placed in service for the years ended December 31, 2014 and 2013. In both 2014 and 2013, we capitalized approximately $0.1
      million for patent filing costs, for a total investment in patents of approximately $0.8
      million and $0.7
      million as of December 31, 2014 and 2013, respectively.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;No amortization expense of patents was recorded in either of the years ended December 31, 2014 and 2013. These patents were not placed in service for the years ended December 31, 2014 and 2013, or in prior years.&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
  <ltbr:CapitalizedCostsForPatents contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">100000</ltbr:CapitalizedCostsForPatents>
  <ltbr:CapitalizedCostsForPatents contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">100000</ltbr:CapitalizedCostsForPatents>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">800000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">700000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 6. Accounts Payable and Accrued Liabilities&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Accounts payable and accrued expenses (in millions) consisted of the following:&lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;December 31,&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;December 31,&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2014&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2013&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Trade payables&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                0.3
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                0.1
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Accrued expenses and other&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                0.4
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                0.1
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Accrued payroll liabilities&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
                0.0
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
                0.3
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Total&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
                0.7
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
                0.5
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
        &lt;/table&gt;
    &lt;p align="center" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;&amp;#160;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;December 31,&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;December 31,&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2014&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2013&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Trade payables&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            0.3
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            0.1
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Accrued expenses and other&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            0.4
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            0.1
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Accrued payroll liabilities&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
            0.0
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
            0.3
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Total&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
            0.7
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
            0.5
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
  <us-gaap:AccountsPayableTradeCurrentAndNoncurrent contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">300000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
  <us-gaap:AccountsPayableTradeCurrentAndNoncurrent contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">100000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
  <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">400000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
  <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">100000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
  <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">0</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">300000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">700000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">500000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 7. Income Taxes&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      Our tax provision is determined using an estimate of our annual effective tax rate adjusted for discrete items, if any, that are taken into account in the relevant period. The 2014 and 2013 annual effective tax rate is estimated to be a combined
      40% for the U.S. federal and state statutory tax rate. We review tax uncertainties in light of changing facts and circumstances and adjust them accordingly. As of December 31, 2014 and 2013, there were no tax contingencies recorded.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting, and the amounts recognized for income tax purposes. The significant components of deferred tax assets (at a
      40% effective tax rate) as of December 31, 2014 and 2013, respectively, are as follows:
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Deferred Tax Assets&lt;/b&gt;
      (in millions)
    &lt;/p&gt;
    &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;
                  &lt;b&gt;Total&lt;/b&gt;
                &lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;
                  &lt;b&gt;Total&lt;/b&gt;
                &lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="23%"&gt;
                  &lt;b&gt;Deferred Tax Asset&lt;/b&gt;
                &lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                  &lt;b&gt;2014&lt;/b&gt;
                &lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                  &lt;b&gt;2013&lt;/b&gt;
                &lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                  &lt;b&gt;2014&lt;/b&gt;
                &lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                  &lt;b&gt;2013&lt;/b&gt;
                &lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Capitalized start-up costs&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                  4.1
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                  4.6
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                  1.6
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                  1.8
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" valign="bottom"&gt;Stock-based compensation&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="10%"&gt;
                  17.8
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="10%"&gt;
                  17.6
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="10%"&gt;
                  7.1
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="10%"&gt;
                  7.0
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Net operating loss carry-forward&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                  45.6
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                  40.5
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                  18.2
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                  16.2
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" valign="bottom"&gt;Less: valuation allowance&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                  (67.5
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                  (62.7
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                  (26.9
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                  (25.0
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160;Total&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
          &lt;/table&gt;
    &lt;/div&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      We have a net operating loss carry-forward for federal and state tax purposes of approximately $45.6
      million at December 31, 2014, that is potentially available to offset future taxable income, which will begin to expire in the year 2021. For financial reporting purposes, no deferred tax asset was recognized because at December 31, 2014 and 2013, management estimates that it is more likely than not that substantially all of the net operating losses will expire unused. As a result, the amount of the deferred tax assets considered realizable was reduced
      100% by a valuation allowance. The change in the valuation allowance was approximately $1.9
      million and $2
      million for the years ended December 31, 2014 and 2013, respectively. Many of the Company&amp;#8217;s operating expenses in its 2007 and 2006 tax years were classified under the Internal Revenue Code as capitalized &amp;#8220;Startup Costs&amp;#8221;, which did not begin to be deductible for tax purposes until 2008. The Company files a consolidated tax return with its subsidiaries. The Company is no longer subject to U.S. federal, state, or non-U.S. income tax examinations by tax authorities for tax years before 2011, except that earlier years can be examined for the sole purpose of challenging the net operating loss carry-forwards arising in those years.
    &lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;
            &lt;b&gt;Total&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;
            &lt;b&gt;Total&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="23%"&gt;
            &lt;b&gt;Deferred Tax Asset&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            &lt;b&gt;2014&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            &lt;b&gt;2013&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            &lt;b&gt;2014&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            &lt;b&gt;2013&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Capitalized start-up costs&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            4.1
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            4.6
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            1.6
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            1.8
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Stock-based compensation&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            17.8
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            17.6
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            7.1
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            7.0
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Net operating loss carry-forward&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            45.6
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            40.5
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            18.2
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            16.2
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Less: valuation allowance&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            (67.5
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            (62.7
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            (26.9
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            (25.0
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160;Total&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <ltbr:CapitalizedStartUpCosts contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">4100000</ltbr:CapitalizedStartUpCosts>
  <ltbr:CapitalizedStartUpCosts contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">4600000</ltbr:CapitalizedStartUpCosts>
  <ltbr:CapitalizedStartUpCosts contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">1600000</ltbr:CapitalizedStartUpCosts>
  <ltbr:CapitalizedStartUpCosts contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">1800000</ltbr:CapitalizedStartUpCosts>
  <ltbr:DeferredTaxAssetsShareBasedCompensation contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">17800000</ltbr:DeferredTaxAssetsShareBasedCompensation>
  <ltbr:DeferredTaxAssetsShareBasedCompensation contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">17600000</ltbr:DeferredTaxAssetsShareBasedCompensation>
  <ltbr:DeferredTaxAssetsShareBasedCompensation contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">7100000</ltbr:DeferredTaxAssetsShareBasedCompensation>
  <ltbr:DeferredTaxAssetsShareBasedCompensation contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">7000000</ltbr:DeferredTaxAssetsShareBasedCompensation>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">45600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">40500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">18200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">16200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">67500000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">62700000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">26900000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">25000000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsNet contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsNet contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsNet contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsNet contextRef="cx_31_December_2013_StatementScenarioAxis-ApproximationsMember_ValuationAllowanceByDeferredTaxAssetAxis-DeferredTaxAssetAmountMember" unitRef="usd" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="pure" decimals="2">0.40</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="pure" decimals="2">0.40</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">45600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">1900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">2000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <ltbr:ValuationAllowance contextRef="cx_31_December_2013" unitRef="pure" decimals="2">1.00</ltbr:ValuationAllowance>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			&lt;b&gt;Note 8. Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Operating Leases&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			On October 16, 2013, we entered into a 1 year sub-lease agreement with our current landlord for our current office space starting January 1, 2014 and terminating December 31, 2014. The monthly rent payment was approximately $32,000 plus additional charges. On January 1, 2015 we entered into a new sub-lease for our current office space for 38 months, with a monthly rent payment of approximately $32,000 per month plus additional charges.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			We paid rent for our Moscow office of approximately $12,000 per month, on a month-to-month basis for the year ended December 31, 2014. The Company will discontinue renting its Moscow office in 2015.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Total rent expense was approximately $0.5 million and $0.7 million for the years ended December 31, 2014 and 2013.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Litigation&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			Our former Chief Financial Officer, filed a complaint against the Company and Seth Grae, President and Chief Executive Officer, with the Circuit Court of Fairfax County, Virginia (the &amp;#8220;Fairfax County Complaint&amp;#8221;), and a separate complaint against the Company with the U.S. Occupational Safety and Health Administration (the &amp;#8220;OSHA Complaint&amp;#8221;) on March 9, 2015.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			The Fairfax County Complaint contained two claims for damages. The first claim alleged that the Company and Mr. Grae made defamatory statements regarding the former Chief Financial Officer. The claim demands at least $1,000,000 in compensatory damages; costs, including reasonable fees for attorneys; and punitive damages of $1,000,000. The second claim alleges that the Company breached the former Chief Financial Officer employment contract by not paying the former Chief Financial Officer $15,507.19 for paid time off, and demands additional compensatory damages of at least $15,507.19.&lt;/p&gt;
				&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			The OSHA Complaint alleges that the Company unlawfully retaliated against the former Chief Financial Officer for challenging allegedly improper actions of the Company by making allegedly defamatory statements and terminating him from his employment with the Company. The former Chief Financial Officer&amp;#8217;s demand for damages is for back pay, front pay, and special damages. The complaint did not specify the amount of damages sought.&lt;/p&gt;
		&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
			The Company believes that all of the claims by the former Chief Financial Officer are without merit and intends to vigorously defend itself.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <ltbr:OperatingLeaseTerm contextRef="cx_01_October_2013_TO_16_October_2013">P1Y</ltbr:OperatingLeaseTerm>
  <us-gaap:LeaseAndRentalExpense contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">32000</us-gaap:LeaseAndRentalExpense>
  <ltbr:OperatingLeaseTerm contextRef="cx_01_January_2014_TO_31_December_2014">P38M</ltbr:OperatingLeaseTerm>
  <us-gaap:LeaseAndRentalExpense contextRef="cx_01_October_2013_TO_16_October_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">32000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:LeaseAndRentalExpense contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_LeaseAgreementAxis-MoscowOfficeMember" unitRef="usd" decimals="0">12000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">500000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">700000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:LossContingencyDamagesSoughtValue contextRef="cx_01_January_2014_TO_31_December_2014_LitigationCaseAxis-FairfaxCountyComplaintOneMember" unitRef="usd" decimals="0">1000000</us-gaap:LossContingencyDamagesSoughtValue>
  <us-gaap:LossContingencyDamagesSoughtValue contextRef="cx_01_January_2014_TO_31_December_2014_LitigationCaseAxis-FairfaxCountyComplaintTwoMember" unitRef="usd" decimals="2">15507.19</us-gaap:LossContingencyDamagesSoughtValue>
  <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 9. Research and Development Costs&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Research and Development Costs&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      Research and development costs, included in the accompanying consolidated statement of operations amounted to approximately $1.5
      million and $2.0
      million for each of the years ended December 31, 2014 and 2013, respectively. We intend to close our Moscow office in 2015 and focus our research and development in Canada.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;On October 20, 2014, we announced the signing of an initial cooperation agreement with Canadian Nuclear Laboratories (&amp;#8220;CNL&amp;#8221;), formerly known as Atomic Energy of Canada Limited-Chalk River Laboratories, for fabrication and test reactor irradiation of Lightbridge's patented next generation metallic nuclear fuel samples. The work will take place at CNL's facilities at Chalk River, Ontario, Canada. The joint work will proceed in three phases that will address:&lt;/p&gt;
    &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="center"&gt;
            &lt;b&gt;&amp;#8226;&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="left" width="90%"&gt;Quality management planning to ensure compliance with the U.S. Nuclear Regulatory Commission requirements for fabrication and loop irradiation testing of fuel samples (Phase I);&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="center"&gt;&amp;#160;&lt;/td&gt;
          &lt;td width="90%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="center"&gt;
            &lt;b&gt;&amp;#8226;&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="left" width="90%"&gt;Development of a fabrication plan and a preliminary experiment design for loop irradiation testing (Phase II); and&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="center"&gt;&amp;#160;&lt;/td&gt;
          &lt;td width="90%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="center"&gt;
            &lt;b&gt;&amp;#8226;&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="left" width="90%"&gt;Fabrication and irradiation of Lightbridge-designed metallic fuel samples (Phase III).&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The Initial Cooperation Agreement enables the Phase I work. Over the next several months, we intend to complete negotiations relating to two other enabling agreements:&lt;/p&gt;
    &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="center"&gt;
            &lt;b&gt;&amp;#8226;&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="left" width="90%"&gt;Nuclear Engineering Services Agreement that will address Phase II; and&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="center"&gt;&amp;#160;&lt;/td&gt;
          &lt;td width="90%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="center"&gt;
            &lt;b&gt;&amp;#8226;&lt;/b&gt;
          &lt;/td&gt;
          &lt;td align="left" width="90%"&gt;Umbrella Services Agreement that will provide a comprehensive legal framework for multi-year cooperation between the parties to enable the final phase of work to proceed.&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The Initial Cooperation Agreement is non-exclusive and does not prevent either party from working with other fuel fabrication or fuel development partners.&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      We have consulting agreements with several consultants working on various projects for us, which total approximately $10,000
      per month.
    &lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
  <ltbr:ResearchAndDevelopmentCosts contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">1500000</ltbr:ResearchAndDevelopmentCosts>
  <ltbr:ResearchAndDevelopmentCosts contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="-5">2000000</ltbr:ResearchAndDevelopmentCosts>
  <ltbr:ConsultingAgreementMontlyPayments contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">10000</ltbr:ConsultingAgreementMontlyPayments>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 10. Stockholders&amp;#8217; Equity&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      At December 31, 2014 and 2013, there are
      500,000,000
      shares of authorized common stock. Total common stock outstanding at December 31, 2014 and 2013, was
      18,082,874
      shares and
      15,057,243
      shares, respectively. At December 31, 2014, there were
      4,886,764
      stock warrants and
      2,026,564
      stock options outstanding, all totaling
      24,996,202
      of total stock and stock equivalents outstanding at December 31, 2014.
    &lt;/p&gt;
        &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;u&gt;Registered Direct Offerings and Outstanding Warrants&lt;/u&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;u&gt;November 12, 2014 Offering&lt;/u&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      On November 12, 2014 we completed an offering with one existing institutional investor pursuant to which the Company sold an aggregate of
      2,878,516
      shares of its common stock and warrants to purchase a total of
      2,734,590
      shares of its common stock for aggregate gross proceeds, before deducting fees to the Placement Agent and other estimated offering expenses payable by the Company, of approximately $5
      million. The common stock and warrants were sold in fixed combinations, with each combination consisting of one share of common stock and a warrant to purchase
      0.95
      shares of common stock. The purchase price is $1.75
      per fixed combination. The warrants will become exercisable six months and one day following the closing date of the Offering and will remain exercisable for seven-and-a-half years from the date of issuance at an exercise price of $2.31
      per share. The exercise price of the warrants is subject to adjustment in the case of stock splits, stock dividends, combinations of shares, and similar recapitalization transactions. The exercisability of the warrants may be limited if, upon exercise, the holder or any of its affiliates would beneficially own more than
      4.99% of the Company's common stock. This limit may be increased to up to
      19.99% upon no fewer than
      60
      days' notice to the Company.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      We received net proceeds of approximately $4.5
      million after payment of certain fees and expenses related to the Offering. The allocation of the proceeds from the offering, based on the relative fair value of the common stock and the warrants, resulted in the allocation of approximately $2.7
      million of the net proceeds to the common stock sold and approximately $1.8
      million of the net proceeds to the warrants, which was recorded to additional paid-in capital-stock and stock equivalents.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      The value of the warrants issued was calculated by using the Black Scholes Valuation Model using the following assumptions: volatility
      67%; risk-free interest rate of
      2.07%; dividend yield of
      0%, and expected term of
      7.5
      years. The volatility of the Company&amp;#8217;s common stock was estimated by management based on the historical volatility of the trading history of the Company&amp;#8217;s common stock. The risk-free interest rate was based on the Treasury Constant Maturity Rates published by the U.S. Federal Reserve for periods applicable to the expected life of the warrants. The expected dividend yield was based on the Company&amp;#8217;s current and expected dividend policy and the expected term is equal to the contractual life of the warrants.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;u&gt;October 21, 2013 Offering&lt;/u&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      On October 21, 2013, we completed an offering with certain institutional investors on the sale of
      2,500,000
      shares of our common stock and warrants to purchase a total of
      1,250,000
      shares of our common stock for aggregate gross proceeds, before deducting fees to the Placement Agent and other estimated offering expenses payable by us, of approximately $4.4
      million. The common stock and warrants were sold in fixed combinations, with each combination consisting of one share of common stock and a warrant to purchase
      0.5
      shares of common stock. The purchase price was $1.75
      per fixed combination. The warrants become exercisable nine months and one day following the closing date (October 21, 2013, i.e., exercisable beginning April 22, 2014) of the offering and will remain exercisable for
      7.5
      years from the date of issuance at an exercise price of $2.30
      per share. The exercise price of the warrants is subject to adjustment in the case of stock splits, stock dividends, combinations of shares, and similar recapitalization transactions. The exercisability of some of the warrants may be limited if, upon exercise, the holder or any of its affiliates would beneficially own more than
      4.99% of our common stock. This limit may be increased to up to
      9.99% upon no fewer than
      60
      days' notice.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      We received net proceeds of approximately $4.0
      million after payment of certain fees and expenses related to the Offering. The allocation of the proceeds from the offering, based on the relative fair value of the common stock and the warrants, resulted in the allocation of approximately $2.8
      million of the net proceeds to the common stock sold and approximately $1.2
      million of the net proceeds to the warrants, which was recorded to additional paid-in capital-stock and stock equivalents.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      The value of the warrants issued was calculated by using the Black Scholes Valuation Model using the following assumptions: volatility
      104%; risk-free interest rate of
      2.01%; dividend yield of
      0%, and expected term of
      7.5
      years. The volatility of the Company&amp;#8217;s common stock was estimated by management based on the historical volatility of the trading history of the Company&amp;#8217;s common stock. The risk-free interest rate was based on the Treasury Constant Maturity Rates published by the U.S. Federal Reserve for periods applicable to the expected life of the warrants. The expected dividend yield was based on the Company&amp;#8217;s current and expected dividend policy and the expected term is equal to the contractual life of the warrants. As of December 31, 2014,
      1,117,178
      of these warrants remain outstanding.
    &lt;/p&gt;
        &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;u&gt;July 22, 2010 Offering&lt;/u&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      On July 22, 2010, we completed an offering (the &amp;#8220;Offering&amp;#8221;) with certain institutional investors on the sale of
      2,069,992
      shares of our common stock and warrants to purchase a total of
      1,034,996
      shares of our common stock for aggregate gross proceeds, before deducting fees to the Placement Agent and other estimated offering expenses payable by us, of approximately $13.7
      million. The common stock and warrants were sold in fixed combinations, with each combination consisting of one share of common stock and a warrant to purchase
      0.5
      shares of common stock. The purchase price was $6.60
      per fixed combination. The warrants became exercisable nine months and one day following the closing date (July 28, 2010, i.e., exercisable beginning January 29, 2011) of the Offering and will remain exercisable for seven years from the date of issuance at an exercise price of $9.00
      per share. The exercise price of the warrants is subject to adjustment in the case of stock splits, stock dividends, combinations of shares, and similar recapitalization transactions. The exercisability of some of the warrants may be limited if, upon exercise, the holder or any of its affiliates would beneficially own more than
      4.99% of our common stock. This limit may be increased to up to
      9.99% upon no fewer than 60 days' notice. All these warrants remain outstanding at December 31, 2014.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;u&gt;Outstanding Warrants&lt;/u&gt;
    &lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"&gt;December 31,&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2014&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2013&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Issued to Investors on July 28,2010, entitling the holders to purchase&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
                1,034,996
                common shares in the Company at an exercise price of
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
                $9.00
                per common share up to and including July 27, 2017
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                1,034,996
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                1,034,996
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Issued to Investors on October 25, 2013, entitling the holders to&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
                purchase
                1,250,000
                common shares in the Company at an exercise
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
                price of $2.30
                per common share up to and including April 24, 2021
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                1,117,178
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                1,250,000
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Issued to Investors on November 17, 2014, entitling the holders to&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
                purchase
                2,734,590
                common shares in the Company at an exercise
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
                price of $2.31
                per common share up to and including May 16, 2022
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
                2,734,590
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
                0
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
                4,886,764
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
                2,284,996
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
        &lt;/table&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;u&gt;Exercise of Warrants &amp;#8211; Q3-2014&lt;/u&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      On September 3, 2014, we issued
      132,822
      shares of our common stock upon the exercise of warrants issued in conjunction with the October 21, 2013 stock offering. We received $2.30
      for each share or $305,931.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Stock-based Compensation &amp;#8211; Stock Options and Restricted Stock&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Stock Plan&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      We have a stock-based compensation plan to reward for services rendered by officers, directors, employees, and consultants. On July 17, 2006, we amended this stock plan. We have reserved
      2,500,000
      shares of common stock of our unissued share capital for the stock plan. Other limitations are as follows:
    &lt;/p&gt;
    &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr&gt;
          &lt;td valign="top" width="5%"&gt;(i)&lt;/td&gt;
          &lt;td&gt;
            &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;
              No more than an aggregate of
              1,250,000
              shares can be granted for the purchase of restricted common shares during the term of the stock plan;
            &lt;/p&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="top" width="5%"&gt;(ii)&lt;/td&gt;
          &lt;td&gt;
            &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;
              The maximum number of shares of common stock with respect to which options may be granted to any one person during any fiscal year may not exceed
              266,667
              shares; and
            &lt;/p&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr&gt;
          &lt;td valign="top" width="5%"&gt;(iii)&lt;/td&gt;
          &lt;td&gt;
            &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;
              The maximum number of restricted shares that may be granted to any one person during any fiscal year may not exceed
              166,667
              common shares.
            &lt;/p&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      Total stock options outstanding at December 31, 2014 and December 31, 2013, were
      2,026,564
      and
      1,564,257, of which
      1,564,257
      and
      1,530,200
      of these options were vested at December 31, 2014 and December 31, 2013, respectively. Stock option expense was approximately $55,000
      and $37,000
      for the quarters ended December 31, 2014 and 2013, respectively. Stock option expense was approximately $262,000
      and $225,000
      for the years ended December 31, 2014 and 2013, respectively.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      On May 5, 2014, we granted
      579,429
      stock options to our employees, directors, and consultants. These stock options vest over three years for employees and consultants, and over one year for our directors. The fair market value of each option was $1.79
      on the grant date, based on (1) The strike price of $2.55, the price of our stock at the close of the market on the grant date; (2) The expected life of the grant of
      5
      years which is equal to the term of the grant, as historically grants have only been exercised just before the term expires; (3) The risk free rate of
      1.68% which is based on the treasury yield curve for a
      5
      year term as published by the U.S. Treasury for the grant date; (4) Volatility of
      90.44%, as measured based on the expected life of the options, and (5) Expected dividends of $0.0, as we have never issued dividends and we have no plans to ever issue dividends. Grants to our consultants were re-measured as of December 31, 2014, and the fair market value of each option was $0.93
      on the measurement date. We estimated future pre-vest forfeitures to be
      1.5%, based on historical information.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Stock option transactions to the employees, directors, advisory board members and consultants are summarized as follows for the year ended December 31, 2014:&lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Weighted&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Weighted&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Options&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Average&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Average&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Outstanding&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Exercise&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Grant Date Fair&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;Price&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;Value&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Beginning of the year&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                1,564,257
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                11.16
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                10.61
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Granted&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                579,429
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                2.55
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                1.79
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Exercised&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Forfeited&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                (117,122
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Expired&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;End of year&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                2,026,564
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                9.19
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                10.61
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td bgcolor="#e6efff" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Options exercisable&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                1,564,257
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                11.16
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                10.61
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
        &lt;/table&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Stock option transactions to the employees, directors, advisory board members and consultants are summarized as follows for the year ended December 31, 2013:&lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Weighted&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Weighted&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Options&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Average&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Average&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Outstanding&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Exercise&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Grant Date Fair&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;Price&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;Value&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Beginning of the year&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                1,639,842
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                11.46
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                10.85
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Granted&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Exercised&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Forfeited&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                (7,250
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                6.04
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="10%"&gt;
                5.51
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Expired&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                (68,335
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                18.94
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
                16.90
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;End of year&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                1,564,257
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                11.16
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                10.61
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td bgcolor="#e6efff" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Options exercisable&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                1,530,200
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                11.28
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
                10.73
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
        &lt;/table&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The above tables include options issued and outstanding as of December 31, 2014, as follows:&lt;/p&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr&gt;
          &lt;td valign="top" width="5%"&gt;i)&lt;/td&gt;
          &lt;td&gt;
            &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;
              A total of
              255,202
              non-qualified
              10
              year options have been issued, and are outstanding, to advisory board members at exercise prices of $4.50
              to $14.40
              per share.
            &lt;/p&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="top" width="5%"&gt;ii)&lt;/td&gt;
          &lt;td&gt;
            &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;
              A total of
              1,579,415
              non-qualified
              5
              -
              10
              year options have been issued, and are outstanding, to our directors, officers, and employees at exercise prices of $2.55
              to $23.85
              per share. From this total,
              820,396
              options are outstanding to the Chief Executive Officer who is also a director, with remaining contractual lives of
              0.9
              years to
              6.2
              years. All other options issued to directors, officers, and employees have a remaining contractual life ranging from
              1.6
              years to
              6.3
              years.
            &lt;/p&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="top" width="5%"&gt;iii)&lt;/td&gt;
          &lt;td&gt;
            &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"&gt;
              A total of
              191,947
              non-qualified
              5
              -
              10
              year options have been issued, and are outstanding, to our consultants at exercise prices of $2.55
              to $15.30
              per share.
            &lt;/p&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;
        &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The following table provides certain information with respect to the above-referenced stock options that are outstanding and exercisable at December 31, 2014:&lt;/p&gt;
    &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="30%"&gt;Stock Options Outstanding&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="30%"&gt;Stock Options Vested&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Weighted&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Weighted&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Average&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Average&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Remaining&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Weighted&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Remaining&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Weighted&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Contractual&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Number&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Average&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Contractual&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Number&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Average&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Life&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;of&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Exercise&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Life&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;of&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="8%"&gt;Exercise&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;-Years&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;Awards&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;Price&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;-Years&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;Awards&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;Price&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff"&gt;Exercise Prices&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left"&gt;
                  $2.55
                  - $5.00
                &lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  4.26
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  645,644
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  3.10
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  4.06
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  183,337
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  4.50
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff"&gt;
                  $5.01
                  - $12.90
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  4.11
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  782,584
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  7.45
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  4.11
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  782,584
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  7.45
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left"&gt;
                  $13.50
                  - $18.90
                &lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  1.30
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  358,336
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  14.17
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  1.30
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  358,336
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  14.17
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff"&gt;
                  $19.20
                  - $23.85
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  1.12
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  240,000
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  23.85
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  1.12
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  240,000
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
                  23.85
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left"&gt;Total&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  3.31
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" width="8%"&gt;
                  2,026,564
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" width="8%"&gt;
                  9.19
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" width="8%"&gt;
                  3.00
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" width="8%"&gt;
                  1,564,257
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" width="8%"&gt;
                  11.16
                &lt;/td&gt;
                &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
          &lt;/table&gt;
    &lt;/div&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The following table provides certain information with respect to the above-referenced stock options that are outstanding and exercisable at December 31, 2013:&lt;/p&gt;
    &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="30%"&gt;Stock Options Outstanding&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="30%"&gt;Stock Options Vested&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Weighted&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Weighted&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Average&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Average&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Remaining&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Weighted&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Remaining&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Weighted&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Contractual&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Number&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Average&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Contractual&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Number&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Average&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Life&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;of&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Exercise&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Life&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;of&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Exercise&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;-Years&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;Awards&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;Price&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;-Years&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;Awards&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;Price&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Exercise Prices&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" valign="bottom"&gt;
                  $2.55
                  - $5.00
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  5.06
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  183,337
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  4.50
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  5.06
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  183,337
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  4.50
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
                  $5.01
                  - $12.90
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  5.11
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  782,584
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  7.45
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  5.03
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  748,527
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  7.53
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" valign="bottom"&gt;
                  $13.50
                  -$18.90
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  2.30
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  358,336
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  14.17
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  2.30
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  358,336
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  14.17
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
                  $19.20
                  -$23.85
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  2.12
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  240,000
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  23.85
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  2.12
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  240,000
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
                  23.85
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" valign="bottom"&gt;Total&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  4.00
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="8%"&gt;
                  1,564,257
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="8%"&gt;
                  11.16
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="8%"&gt;
                  3.94
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="8%"&gt;
                  1,530,200
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="8%"&gt;
                  11.28
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
          &lt;/table&gt;
    &lt;/div&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      The aggregate intrinsic value of stock options outstanding at December 31, 2014 and December 31, 2013, was $0. Intrinsic value is calculated based on the difference between the exercise price of the underlying awards and the quoted price of our common stock as of the reporting date ($1.55
      and $1.45
      per share as of the close on December 31, 2014 and December 31, 2013, respectively).
    &lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;Restricted Stock Award Activity&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Weighted&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Average&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Grant&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Number of&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Date Fair&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;Units&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;Value&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total awards outstanding at December 31, 2012&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                43,032
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                6.49
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Units granted&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Units Exercised/Released&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                (28,739
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                6.99
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Units Cancelled/Forfeited&lt;/td&gt;
              &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total awards outstanding at December 31, 2013&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                14,293
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                5.47
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Units granted&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Units Exercised/Released&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                (14,293
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                5.47
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Units Cancelled/Forfeited&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total awards outstanding at December 31, 2014&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                &amp;#160;
                -
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
        &lt;/table&gt;
        &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;&amp;#160;&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      As of December 31, 2014 and December 31, 2013, there was approximately $0
      and $19,000
      of net unrecognized compensation cost related to unvested restricted stock-based compensation arrangements, respectively. This compensation is recognized on a straight line basis and all of the compensation expected to be expensed in 2014, has been recognized as of December 31, 2014.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      We use the historical volatility of our stock price over the number of years that matches the expected life of our stock option grants or we use the historical volatility of our stock price since January 5, 2006, the date we announced that we were becoming a public company, to estimate the future volatility of our stock. At this time we do not believe that there is a better objective method to predict the future volatility of our stock. We estimate the life of our option awards based on the full term of the award. To date we have had very few exercises of our options, and those exercises have occurred just before the expiration date of the awards. Since the strike price of most of our outstanding awards is greater than the price of our stock, generally awards have expired at the end of the term. We estimate the effect of future forfeitures of our grants based on an analysis of historical forfeitures of unvested grants, as we have no better objective basis for that estimate. The expense that we have recognized related to our grants of options and restricted stock includes the estimate for future pre-vest forfeitures. We will adjust the actual expense recognized due to future pre-vest forfeitures as they occur. We have estimated that
      1.5% and
      0% of our option and restricted stock grants respectively, will be forfeited prior to vesting.
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Assumptions used in the Black Scholes option-pricing model for the year ended December 31, 2014, and for the year ended December 31, 2011, (there were no stock option grants in 2013 and 2012) were as follows:&lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Year ended&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Year ended&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;12/31/2014&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;12/31/2011&lt;/td&gt;
              &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Average risk-free interest rate&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                1.68%
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                3.35%
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Average expected life- years&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                5
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                10
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Expected volatility&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                90.44%
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
                94.32%
              &lt;/td&gt;
              &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr valign="top"&gt;
              &lt;td align="left" valign="bottom"&gt;Expected dividends&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                0
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
              &lt;td align="right" valign="bottom" width="12%"&gt;
                0
              &lt;/td&gt;
              &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
            &lt;/tr&gt;
        &lt;/table&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;Stock-based compensation expense includes the expense related to (1) Grants of stock options, (2) Grants of restricted stock, (3) Stock issued as consideration for some of the services provided by our directors and strategic advisory council members, and (4) Stock issued in lieu of cash to pay bonuses to our employees and contractors. We record stock-based compensation expenses in the caption with all of our other general and administrative expenses. Grants of stock options and restricted stock are awarded to our employees, directors, consultants, and board members, and we recognize the fair market value of these awards ratably as they are earned. The expense related to payments in stock for services is recognized as the services are provided.&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      During the years ended December 31, 2014 and 2013, approximately $0.3
      million was recorded as total stock-based compensation each year. Stock-based compensation expense is recorded under the captions general and administrative expenses and research and development expenses in the accompanying consolidated statements of operations.
    &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"&gt;December 31,&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2014&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;2013&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Issued to Investors on July 28,2010, entitling the holders to purchase&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
            1,034,996
            common shares in the Company at an exercise price of
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
            $9.00
            per common share up to and including July 27, 2017
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            1,034,996
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            1,034,996
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Issued to Investors on October 25, 2013, entitling the holders to&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
            purchase
            1,250,000
            common shares in the Company at an exercise
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
            price of $2.30
            per common share up to and including April 24, 2021
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            1,117,178
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            1,250,000
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Issued to Investors on November 17, 2014, entitling the holders to&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
            purchase
            2,734,590
            common shares in the Company at an exercise
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
            price of $2.31
            per common share up to and including May 16, 2022
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
            2,734,590
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
            0
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
            4,886,764
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
            2,284,996
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:CommonStockOtherSharesOutstanding contextRef="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember" unitRef="shares" decimals="0">1034996</us-gaap:CommonStockOtherSharesOutstanding>
  <invest:InvestmentWarrantsExercisePrice contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember" unitRef="usd_shares" decimals="2">9.00</invest:InvestmentWarrantsExercisePrice>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember" unitRef="shares" decimals="0">1034996</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2013_EquityTransactionAxis-IssuedToInvestorsOnJulyTwoEightTwoZeroOneZeroMember" unitRef="shares" decimals="0">1034996</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:CommonStockOtherSharesOutstanding contextRef="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember" unitRef="shares" decimals="0">1250000</us-gaap:CommonStockOtherSharesOutstanding>
  <invest:InvestmentWarrantsExercisePrice contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember" unitRef="usd_shares" decimals="2">2.30</invest:InvestmentWarrantsExercisePrice>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember" unitRef="shares" decimals="0">1117178</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2013_EquityTransactionAxis-IssuedToInvestorsOnOctoberTwoFiveTwoZeroOneThreeMember" unitRef="shares" decimals="0">1250000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:CommonStockOtherSharesOutstanding contextRef="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember" unitRef="shares" decimals="0">2734590</us-gaap:CommonStockOtherSharesOutstanding>
  <invest:InvestmentWarrantsExercisePrice contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember" unitRef="usd_shares" decimals="2">2.31</invest:InvestmentWarrantsExercisePrice>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2014_EquityTransactionAxis-IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember" unitRef="shares" decimals="0">2734590</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2013_EquityTransactionAxis-IssuedToInvestorsOnNovemberOneSevenTwoZeroOneFourMember" unitRef="shares" decimals="0">0</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2014" unitRef="shares" decimals="0">4886764</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2013" unitRef="shares" decimals="0">2284996</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Weighted&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Weighted&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Options&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Average&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Average&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Outstanding&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Exercise&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Grant Date Fair&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;Price&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;Value&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Beginning of the year&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            1,564,257
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            11.16
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            10.61
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Granted&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            579,429
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            2.55
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            1.79
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Exercised&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Forfeited&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            (117,122
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Expired&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;End of year&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            2,026,564
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            9.19
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            10.61
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td bgcolor="#e6efff" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Options exercisable&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            1,564,257
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            11.16
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            10.61
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2013" unitRef="shares" decimals="0">1564257</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="2">11.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompenationWeightedAverageFairValue contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="2">10.61</ltbr:ShareBasedCompenationWeightedAverageFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="shares" decimals="0">579429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="2">2.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsGranted contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="2">1.79</ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsGranted>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="shares" decimals="0">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <ltbr:ShareBasedCompensationWeightedAverageExercisePriceStockOptionsExercised contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="0">0</ltbr:ShareBasedCompensationWeightedAverageExercisePriceStockOptionsExercised>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsExercised contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="0">0</ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="shares" decimals="0">-117122</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsForfeited contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="0">0</ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsForfeited>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsExpired contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd_shares" decimals="0">0</ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsExpired>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2014" unitRef="shares" decimals="0">2026564</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2014" unitRef="usd_shares" decimals="2">9.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueEndOfYear contextRef="cx_31_December_2014" unitRef="usd_shares" decimals="2">10.61</ltbr:ShareBasedCompensationWeightedAverageFairValueEndOfYear>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="cx_31_December_2014" unitRef="shares" decimals="0">1564257</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2014" unitRef="usd_shares" decimals="2">11.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueOptionsExerciseable contextRef="cx_31_December_2014" unitRef="usd_shares" decimals="2">10.61</ltbr:ShareBasedCompensationWeightedAverageFairValueOptionsExerciseable>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="cx_01_January_2013_TO_31_December_2013">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Weighted&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Weighted&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Options&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Average&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Average&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Outstanding&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Exercise&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="10%"&gt;Grant Date Fair&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;Price&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;Value&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Beginning of the year&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            1,639,842
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            11.46
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            10.85
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Granted&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Exercised&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="10%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Forfeited&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            (7,250
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            6.04
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="10%"&gt;
            5.51
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Expired&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            (68,335
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            18.94
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"&gt;
            16.90
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;End of year&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            1,564,257
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            11.16
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            10.61
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td bgcolor="#e6efff" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="10%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Options exercisable&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            1,530,200
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            11.28
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"&gt;
            10.73
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2012" unitRef="shares" decimals="0">1639842</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2012" unitRef="usd_shares" decimals="2">11.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompenationWeightedAverageFairValue contextRef="cx_31_December_2012" unitRef="usd_shares" decimals="2">10.85</ltbr:ShareBasedCompenationWeightedAverageFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsGranted contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="0">0</ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsGranted>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="shares" decimals="0">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <ltbr:ShareBasedCompensationWeightedAverageExercisePriceStockOptionsExercised contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="0">0</ltbr:ShareBasedCompensationWeightedAverageExercisePriceStockOptionsExercised>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsExercised contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="0">0</ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="shares" decimals="0">-7250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="2">6.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsForfeited contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="2">5.51</ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsForfeited>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="shares" decimals="0">-68335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="2">18.94</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsExpired contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd_shares" decimals="2">16.90</ltbr:ShareBasedCompensationWeightedAverageFairValueStockOptionsExpired>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueEndOfYear contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="2">10.61</ltbr:ShareBasedCompensationWeightedAverageFairValueEndOfYear>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="cx_31_December_2013" unitRef="shares" decimals="0">1530200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="2">11.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <ltbr:ShareBasedCompensationWeightedAverageFairValueOptionsExerciseable contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="2">10.73</ltbr:ShareBasedCompensationWeightedAverageFairValueOptionsExerciseable>
  <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="30%"&gt;Stock Options Outstanding&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="30%"&gt;Stock Options Vested&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Weighted&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Weighted&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Average&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Average&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Remaining&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Weighted&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Remaining&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Weighted&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Contractual&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Number&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Average&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Contractual&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Number&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Average&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Life&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;of&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Exercise&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Life&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;of&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="8%"&gt;Exercise&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;-Years&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;Awards&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;Price&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;-Years&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;Awards&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="8%"&gt;Price&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff"&gt;Exercise Prices&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left"&gt;
            $2.55
            - $5.00
          &lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            4.26
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            645,644
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            3.10
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            4.06
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            183,337
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            4.50
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff"&gt;
            $5.01
            - $12.90
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            4.11
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            782,584
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            7.45
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            4.11
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            782,584
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            7.45
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left"&gt;
            $13.50
            - $18.90
          &lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            1.30
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            358,336
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            14.17
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            1.30
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            358,336
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            14.17
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff"&gt;
            $19.20
            - $23.85
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            1.12
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            240,000
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            23.85
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            1.12
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            240,000
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" width="8%"&gt;
            23.85
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left"&gt;Total&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            3.31
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" width="8%"&gt;
            2,026,564
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" width="8%"&gt;
            9.19
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" width="8%"&gt;
            3.00
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" width="8%"&gt;
            1,564,257
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" width="8%"&gt;
            11.16
          &lt;/td&gt;
          &lt;td align="left" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="usd_shares" decimals="2">2.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="usd_shares" decimals="2">5.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember">P4Y3M4D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="shares" decimals="0">645644</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="usd_shares" decimals="2">3.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember">P4Y22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="shares" decimals="0">183337</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="usd_shares" decimals="2">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="usd_shares" decimals="2">5.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="usd_shares" decimals="2">12.90</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember">P4Y1M10D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="shares" decimals="0">782584</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="usd_shares" decimals="2">7.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember">P4Y1M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="shares" decimals="0">782584</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="usd_shares" decimals="2">7.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="usd_shares" decimals="2">13.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="usd_shares" decimals="2">18.90</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember">P1Y3M18D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="shares" decimals="0">358336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="usd_shares" decimals="2">14.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember">P1Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="shares" decimals="0">358336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="usd_shares" decimals="2">14.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="usd_shares" decimals="2">19.20</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="usd_shares" decimals="2">23.85</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember">P1Y1M13D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="shares" decimals="0">240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="usd_shares" decimals="2">23.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember">P1Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="shares" decimals="0">240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2014_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="usd_shares" decimals="2">23.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2014_TO_31_December_2014">P3Y3M22D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2014" unitRef="shares" decimals="0">1564257</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2014" unitRef="usd_shares" decimals="2">11.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="cx_01_January_2013_TO_31_December_2013">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="30%"&gt;Stock Options Outstanding&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="30%"&gt;Stock Options Vested&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Weighted&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Weighted&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Average&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Average&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Remaining&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Weighted&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Remaining&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Weighted&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Contractual&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Number&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Average&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Contractual&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Number&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Average&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Life&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;of&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Exercise&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Life&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;of&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="8%"&gt;Exercise&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;-Years&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;Awards&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;Price&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;-Years&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;Awards&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="8%"&gt;Price&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Exercise Prices&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="8%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;
            $2.55
            - $5.00
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            5.06
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            183,337
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            4.50
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            5.06
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            183,337
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            4.50
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
            $5.01
            - $12.90
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            5.11
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            782,584
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            7.45
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            5.03
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            748,527
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            7.53
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;
            $13.50
            -$18.90
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            2.30
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            358,336
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            14.17
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            2.30
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            358,336
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            14.17
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;
            $19.20
            -$23.85
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            2.12
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            240,000
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            23.85
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            2.12
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            240,000
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="8%"&gt;
            23.85
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Total&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            4.00
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="8%"&gt;
            1,564,257
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="8%"&gt;
            11.16
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="8%"&gt;
            3.94
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="8%"&gt;
            1,530,200
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="8%"&gt;
            11.28
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="usd_shares" decimals="2">2.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="usd_shares" decimals="2">5.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember">P5Y22D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="shares" decimals="0">183337</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="usd_shares" decimals="2">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember">P5Y22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="shares" decimals="0">183337</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember" unitRef="usd_shares" decimals="2">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="usd_shares" decimals="2">5.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="usd_shares" decimals="2">12.90</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember">P5Y1M10D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="shares" decimals="0">782584</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="usd_shares" decimals="2">7.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember">P5Y11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="shares" decimals="0">748527</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeTwoMember" unitRef="usd_shares" decimals="2">7.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="usd_shares" decimals="2">13.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="usd_shares" decimals="2">18.90</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember">P2Y3M18D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="shares" decimals="0">358336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="usd_shares" decimals="2">14.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember">P2Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="shares" decimals="0">358336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeThreeMember" unitRef="usd_shares" decimals="2">14.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="usd_shares" decimals="2">19.20</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="usd_shares" decimals="2">23.85</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember">P2Y1M13D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="shares" decimals="0">240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="usd_shares" decimals="2">23.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2013_TO_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember">P2Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="shares" decimals="0">240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2013_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeFourMember" unitRef="usd_shares" decimals="2">23.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="cx_01_January_2013_TO_31_December_2013">P4Y</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2013_TO_31_December_2013">P3Y11M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="cx_31_December_2013" unitRef="shares" decimals="0">1530200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="2">11.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;Restricted Stock Award Activity&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Weighted&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Average&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Grant&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Number of&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Date Fair&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;Units&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;Value&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total awards outstanding at December 31, 2012&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            43,032
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            6.49
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Units granted&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Units Exercised/Released&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            (28,739
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            6.99
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Units Cancelled/Forfeited&lt;/td&gt;
          &lt;td align="left" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total awards outstanding at December 31, 2013&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            14,293
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            5.47
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Units granted&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Units Exercised/Released&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            (14,293
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            5.47
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Units Cancelled/Forfeited&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total awards outstanding at December 31, 2014&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"&gt;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="cx_31_December_2012_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">43032</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="cx_31_December_2012_AwardTypeAxis-RestrictedStockMember" unitRef="usd_shares" decimals="2">6.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember" unitRef="usd_shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod contextRef="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">-28739</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod>
  <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFai contextRef="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember" unitRef="usd_shares" decimals="2">6.99</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFai>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember" unitRef="usd_shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <ltbr:ShareBasedCompensationArrangementByShareBasedPaymantAwardEquityInstrumentsOtherThanOptions contextRef="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">14293</ltbr:ShareBasedCompensationArrangementByShareBasedPaymantAwardEquityInstrumentsOtherThanOptions>
  <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValuePeriod contextRef="cx_01_January_2013_TO_31_December_2013_AwardTypeAxis-RestrictedStockMember" unitRef="usd_shares" decimals="2">5.47</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValuePeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-RestrictedStockMember" unitRef="usd_shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">-14293</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod>
  <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFai contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-RestrictedStockMember" unitRef="usd_shares" decimals="2">5.47</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFai>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <ltbr:ShareBasedCompensationArrangementByShareBasedPaymantAwardEquityInstrumentsOtherThanOptions contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-RestrictedStockMember" unitRef="shares" decimals="0">0</ltbr:ShareBasedCompensationArrangementByShareBasedPaymantAwardEquityInstrumentsOtherThanOptions>
  <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValuePeriod contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-RestrictedStockMember" unitRef="usd_shares" decimals="0">0</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValuePeriod>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Year ended&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;Year ended&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;12/31/2014&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="12%"&gt;12/31/2011&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="12%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Average risk-free interest rate&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            1.68%
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            3.35%
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Average expected life- years&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            5
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            10
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Expected volatility&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            90.44%
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="12%"&gt;
            94.32%
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Expected dividends&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            0
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="12%"&gt;
            0
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-EmployeeStockOptionMember" unitRef="pure" decimals="4">0.0168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="cx_01_January_2011_TO_31_December_2011_AwardTypeAxis-EmployeeStockOptionMember" unitRef="pure" decimals="4">0.0335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-EmployeeStockOptionMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="cx_01_January_2011_TO_31_December_2011_AwardTypeAxis-EmployeeStockOptionMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-EmployeeStockOptionMember" unitRef="pure" decimals="4">0.9044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="cx_01_January_2011_TO_31_December_2011_AwardTypeAxis-EmployeeStockOptionMember" unitRef="pure" decimals="4">0.9432</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-EmployeeStockOptionMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="cx_01_January_2011_TO_31_December_2011_AwardTypeAxis-EmployeeStockOptionMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:CommonStockSharesOutstanding contextRef="cx_31_December_2014_AwardTypeAxis-StockAndStockEquivalentsMember" unitRef="shares" decimals="0">24996202</us-gaap:CommonStockSharesOutstanding>
  <ltbr:CommonStockAndWarrantsSold contextRef="cx_01_October_2013_TO_21_October_2013_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="usd" decimals="0">2878516</ltbr:CommonStockAndWarrantsSold>
  <us-gaap:CommonStockOtherSharesOutstanding contextRef="cx_21_October_2013_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="shares" decimals="0">2734590</us-gaap:CommonStockOtherSharesOutstanding>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="cx_01_October_2013_TO_21_October_2013_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="usd" decimals="-6">5000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <ltbr:SharesOfCommonStockToBePurchasedByFixedCombination contextRef="cx_21_October_2013_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="shares" decimals="2">0.95</ltbr:SharesOfCommonStockToBePurchasedByFixedCombination>
  <ltbr:PurchasePriceOfFixedCombination contextRef="cx_21_October_2013_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="usd" decimals="2">1.75</ltbr:PurchasePriceOfFixedCombination>
  <invest:InvestmentWarrantsExercisePrice contextRef="cx_01_October_2013_TO_21_October_2013_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="usd_shares" decimals="2">2.31</invest:InvestmentWarrantsExercisePrice>
  <ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants contextRef="cx_21_October_2013_RangeAxis-MinimumMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="pure" decimals="4">0.0499</ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants>
  <ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants contextRef="cx_21_October_2013_RangeAxis-MaximumMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="pure" decimals="4">0.1999</ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants>
  <ltbr:NetProceedsFromTheOfferingReceivedAfterPaymentsOfFeesAndExpenses contextRef="cx_21_October_2013_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="usd" decimals="-5">4500000</ltbr:NetProceedsFromTheOfferingReceivedAfterPaymentsOfFeesAndExpenses>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="usd" decimals="-5">2700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
  <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember" unitRef="usd" decimals="-5">1800000</us-gaap:ProceedsFromIssuanceOfWarrants>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember_AwardTypeAxis-WarrantMember" unitRef="pure" decimals="2">0.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember_AwardTypeAxis-WarrantMember" unitRef="pure" decimals="4">0.0207</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember_AwardTypeAxis-WarrantMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-NovemberOneTwoTwoZeroOneFourOfferingMember_AwardTypeAxis-WarrantMember">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <ltbr:CommonStockAndWarrantsSold contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="0">2500000</ltbr:CommonStockAndWarrantsSold>
  <us-gaap:CommonStockOtherSharesOutstanding contextRef="cx_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="shares" decimals="0">1250000</us-gaap:CommonStockOtherSharesOutstanding>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="-5">4400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <ltbr:SharesOfCommonStockToBePurchasedByFixedCombination contextRef="cx_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="shares" decimals="1">0.5</ltbr:SharesOfCommonStockToBePurchasedByFixedCombination>
  <ltbr:PurchasePriceOfFixedCombination contextRef="cx_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="2">1.75</ltbr:PurchasePriceOfFixedCombination>
  <us-gaap:DerivativeTermOfContract contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember">P7Y6M</us-gaap:DerivativeTermOfContract>
  <invest:InvestmentWarrantsExercisePrice contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd_shares" decimals="2">2.30</invest:InvestmentWarrantsExercisePrice>
  <ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants contextRef="cx_31_December_2014_RangeAxis-MinimumMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="pure" decimals="4">0.0499</ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants>
  <ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants contextRef="cx_31_December_2014_RangeAxis-MaximumMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="pure" decimals="4">0.0999</ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants>
  <ltbr:NetProceedsFromTheOfferingReceivedAfterPaymentsOfFeesAndExpenses contextRef="cx_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="-5">4000000</ltbr:NetProceedsFromTheOfferingReceivedAfterPaymentsOfFeesAndExpenses>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="-5">2800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
  <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="-5">1200000</us-gaap:ProceedsFromIssuanceOfWarrants>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-WarrantMember" unitRef="pure" decimals="2">1.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="pure" decimals="4">0.0201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-WarrantMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_AwardTypeAxis-WarrantMember">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="cx_31_December_2014_AwardTypeAxis-WarrantMember" unitRef="shares" decimals="0">1117178</us-gaap:ClassOfWarrantOrRightOutstanding>
  <ltbr:CommonStockAndWarrantsSold contextRef="cx_01_July_2010_TO_22_July_2010_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="0">2069992</ltbr:CommonStockAndWarrantsSold>
  <us-gaap:CommonStockOtherSharesOutstanding contextRef="cx_22_July_2010_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="shares" decimals="0">1034996</us-gaap:CommonStockOtherSharesOutstanding>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="cx_01_July_2010_TO_22_July_2010_StatementScenarioAxis-ApproximationsMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="-5">13700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <ltbr:SharesOfCommonStockToBePurchasedByFixedCombination contextRef="cx_22_July_2010_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="shares" decimals="1">0.5</ltbr:SharesOfCommonStockToBePurchasedByFixedCombination>
  <ltbr:PurchasePriceOfFixedCombination contextRef="cx_22_July_2010_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="2">6.60</ltbr:PurchasePriceOfFixedCombination>
  <invest:InvestmentWarrantsExercisePrice contextRef="cx_01_July_2010_TO_22_July_2010_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd_shares" decimals="2">9.00</invest:InvestmentWarrantsExercisePrice>
  <ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants contextRef="cx_22_July_2010_RangeAxis-MinimumMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="pure" decimals="4">0.0499</ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants>
  <ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants contextRef="cx_22_July_2010_RangeAxis-MaximumMember_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="pure" decimals="4">0.0999</ltbr:MaximumCommonStockOwnershipToBeEligibleForExerciseOfWarrants>
  <us-gaap:CommonStockSharesIssued contextRef="cx_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="shares" decimals="0">132822</us-gaap:CommonStockSharesIssued>
  <us-gaap:EquityIssuancePerShareAmount contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd_shares" decimals="2">2.30</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-RegisteredDirectOfferingAndOutstandingWarrantsMember" unitRef="usd" decimals="0">305931</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="cx_17_July_2006_AwardTypeAxis-StockCompensationPlanMember" unitRef="shares" decimals="0">2500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="cx_17_July_2006_AwardTypeAxis-MaximumRestrictedSharesGrantedMember" unitRef="shares" decimals="0">1250000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="cx_17_July_2006_AwardTypeAxis-MaximumNumberOfSharesInRespectToStockOptionsMember" unitRef="shares" decimals="0">266667</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="cx_17_July_2006_AwardTypeAxis-MaximumRestrictedSharesGrantedToOnePersonMember" unitRef="shares" decimals="0">166667</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:StockOptionPlanExpense contextRef="cx_01_July_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">55000</us-gaap:StockOptionPlanExpense>
  <us-gaap:StockOptionPlanExpense contextRef="cx_01_July_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">37000</us-gaap:StockOptionPlanExpense>
  <us-gaap:StockOptionPlanExpense contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">262000</us-gaap:StockOptionPlanExpense>
  <us-gaap:StockOptionPlanExpense contextRef="cx_01_January_2013_TO_31_December_2013_StatementScenarioAxis-ApproximationsMember" unitRef="usd" decimals="0">225000</us-gaap:StockOptionPlanExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember" unitRef="shares" decimals="0">579429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <ltbr:ShareBasedCompenationWeightedAverageFairValue contextRef="cx_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember" unitRef="usd_shares" decimals="2">1.79</ltbr:ShareBasedCompenationWeightedAverageFairValue>
  <ltbr:StrikePrice contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember" unitRef="usd_shares" decimals="2">2.55</ltbr:StrikePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember" unitRef="pure" decimals="4">0.0168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember" unitRef="pure" decimals="4">0.9044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <ltbr:FairMarketValueOnMeasurementDate contextRef="cx_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember" unitRef="usd_shares" decimals="2">0.93</ltbr:FairMarketValueOnMeasurementDate>
  <ltbr:PreVestingForfeitureRate contextRef="cx_31_December_2014_EquityTransactionAxis-MayFiveTwoZeroOneFourStockOptionsGrantedMember" unitRef="pure" decimals="3">0.015</ltbr:PreVestingForfeitureRate>
  <ltbr:NonQualifiedStockOptions contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfTwoFiveFiveTwoZeroTwoNonqualifiedOneZeroYearOptionsMember" unitRef="shares" decimals="0">255202</ltbr:NonQualifiedStockOptions>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfTwoFiveFiveTwoZeroTwoNonqualifiedOneZeroYearOptionsMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfTwoFiveFiveTwoZeroTwoNonqualifiedOneZeroYearOptionsMember" unitRef="usd_shares" decimals="2">4.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfTwoFiveFiveTwoZeroTwoNonqualifiedOneZeroYearOptionsMember" unitRef="usd_shares" decimals="2">14.40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:NonQualifiedStockOptions contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember" unitRef="shares" decimals="0">1579415</ltbr:NonQualifiedStockOptions>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember_RangeAxis-MinimumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember_RangeAxis-MaximumMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember" unitRef="usd_shares" decimals="2">2.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneFiveSevenNineFourOneFiveNonqualifiedFiveOneZeroYearOptionsMember" unitRef="usd_shares" decimals="2">23.85</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <ltbr:NonQualifiedStockOptions contextRef="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-ChiefExecutiveOfficerMember" unitRef="shares" decimals="0">820396</ltbr:NonQualifiedStockOptions>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-ChiefExecutiveOfficerMember_RangeAxis-MinimumMember">P0Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-ChiefExecutiveOfficerMember_RangeAxis-MaximumMember">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-DirectorMember_RangeAxis-MinimumMember">P1Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_RelatedPartyTransactionsByRelatedPartyAxis-DirectorMember_RangeAxis-MaximumMember">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <ltbr:NonQualifiedStockOptions contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember" unitRef="shares" decimals="0">191947</ltbr:NonQualifiedStockOptions>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember_RangeAxis-MinimumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember_RangeAxis-MaximumMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember" unitRef="usd_shares" decimals="2">2.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="cx_01_January_2014_TO_31_December_2014_EquityTransactionAxis-IssuanceOfOneNineOneNineFourSevenNonqualifiedFiveOneZeroYearOptionsMember" unitRef="usd_shares" decimals="2">15.30</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="cx_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="cx_31_December_2013" unitRef="usd" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue contextRef="cx_31_December_2014" unitRef="usd_shares" decimals="2">1.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue contextRef="cx_31_December_2013" unitRef="usd_shares" decimals="2">1.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue>
  <ltbr:UnrecognizedCompensationCosts contextRef="cx_31_December_2014" unitRef="usd" decimals="0">0</ltbr:UnrecognizedCompensationCosts>
  <ltbr:UnrecognizedCompensationCosts contextRef="cx_31_December_2013" unitRef="usd" decimals="0">19000</ltbr:UnrecognizedCompensationCosts>
  <ltbr:RestrictedStockGrantsEstimatedForfeitureAmount contextRef="cx_31_December_2014" unitRef="pure" decimals="3">0.015</ltbr:RestrictedStockGrantsEstimatedForfeitureAmount>
  <ltbr:RestrictedStockGrantsEstimatedForfeitureAmount contextRef="cx_31_December_2014_AwardTypeAxis-RestrictedStockMember" unitRef="pure" decimals="2">0.00</ltbr:RestrictedStockGrantsEstimatedForfeitureAmount>
  <us-gaap:ShareBasedCompensation contextRef="cx_01_January_2014_TO_31_December_2014_StatementScenarioAxis-ApproximationsMember_AwardTypeAxis-StockbasedCompensationMember" unitRef="usd" decimals="-5">300000</us-gaap:ShareBasedCompensation>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 11. Business Segment Results&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;We have two principal business segments, which are (1) Our technology business and (2) Our consulting services business. These business segments were determined based on the nature of the operations and the services offered. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief decision-makers, in deciding how to allocate resources and in assessing performance. Our Chief Executive Officer and Interim Chief Financial Officer have been identified as the chief operating decision makers. Our chief operating decision makers direct the allocation of resources to operating segments based on the profitability, the cash flows, and the business plans of each respective segment.&lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The Company evaluates performance based on several factors, of which achievement of strategic goals toward future profitability and business segment income before taxes are the primary measures. The following tables show the operations of the Company&amp;#8217;s reportable business segments for the years ended December 31, 2014 and 2013.&lt;/p&gt;
        &lt;p align="center" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;BUSINESS SEGMENT RESULTS - YEARS ENDED DECEMBER 31, 2014 AND 2013&lt;/b&gt;
    &lt;/p&gt;
    &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 8pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Corporate and&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Consulting&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Technology&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Eliminations&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Total&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2014&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2013&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2014&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2013&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2014&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2013&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2014&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2013&lt;/td&gt;
                &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Revenue&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  1,310,199
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  1,901,354
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  1,310,199
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  1,901,354
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" valign="bottom"&gt;Segment Profit - Pre Tax&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  406,078
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  286,299
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  (1,534,605
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  (2,030,194
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  (3,688,517
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  (3,121,065
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  (4,817,044
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  (4,864,961
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total Assets&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  469,086
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  425,916
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  833,560
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  699,168
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  4,750,590
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  4,532,555
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  6,053,236
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  5,657,639
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" valign="bottom"&gt;Property Additions&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Interest Expense&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr valign="top"&gt;
                &lt;td align="left" valign="bottom"&gt;Deprec. Expense&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  17,221
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  &amp;#160;
                  -
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
                &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
                &lt;td align="right" valign="bottom" width="6%"&gt;
                  17,221
                &lt;/td&gt;
                &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
          &lt;/table&gt;
    &lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 8pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Corporate and&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Consulting&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Technology&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Eliminations&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="15%"&gt;Total&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2014&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2013&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2014&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2013&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2014&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2013&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2014&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="1%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="center" nowrap="nowrap" valign="bottom" width="6%"&gt;2013&lt;/td&gt;
          &lt;td align="left" nowrap="nowrap" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Revenue&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            1,310,199
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            1,901,354
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            1,310,199
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            1,901,354
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Segment Profit - Pre Tax&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            406,078
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            286,299
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            (1,534,605
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            (2,030,194
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            (3,688,517
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            (3,121,065
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            (4,817,044
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            (4,864,961
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;)&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Total Assets&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            469,086
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            425,916
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            833,560
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            699,168
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            4,750,590
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            4,532,555
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            6,053,236
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            5,657,639
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Property Additions&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom"&gt;Interest Expense&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" bgcolor="#e6efff" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" bgcolor="#e6efff" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="left" valign="bottom"&gt;Deprec. Expense&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            17,221
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            &amp;#160;
            -
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"&gt;$&lt;/td&gt;
          &lt;td align="right" valign="bottom" width="6%"&gt;
            17,221
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="2%"&gt;&amp;#160;&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
  <us-gaap:Revenues contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">1310199</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">1901354</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">0</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">0</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">0</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">0</us-gaap:Revenues>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">406078</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">286299</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">-1534605</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">-2030194</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">-3688517</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">-3121065</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">-4817044</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">-4864961</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:Assets contextRef="cx_31_December_2014_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">469086</us-gaap:Assets>
  <us-gaap:Assets contextRef="cx_30_September_2013_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">425916</us-gaap:Assets>
  <us-gaap:Assets contextRef="cx_31_December_2014_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">833560</us-gaap:Assets>
  <us-gaap:Assets contextRef="cx_30_September_2013_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">699168</us-gaap:Assets>
  <us-gaap:Assets contextRef="cx_31_December_2014_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">4750590</us-gaap:Assets>
  <us-gaap:Assets contextRef="cx_30_September_2013_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">4532555</us-gaap:Assets>
  <us-gaap:Assets contextRef="cx_30_September_2013" unitRef="usd" decimals="0">5657639</us-gaap:Assets>
  <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">0</us-gaap:PropertyPlantAndEquipmentAdditions>
  <us-gaap:InterestExpense contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">0</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">0</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">0</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">0</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">0</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">0</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">0</us-gaap:InterestExpense>
  <us-gaap:Depreciation contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">0</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-ConsultingMember" unitRef="usd" decimals="0">0</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">0</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-TechnologyMember" unitRef="usd" decimals="0">0</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="cx_01_January_2014_TO_31_December_2014_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">0</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="cx_01_January_2013_TO_31_December_2013_StatementBusinessSegmentsAxis-CorporateAndEliminationsMember" unitRef="usd" decimals="0">17221</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="cx_01_January_2014_TO_31_December_2014" unitRef="usd" decimals="0">0</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="cx_01_January_2013_TO_31_December_2013" unitRef="usd" decimals="0">17221</us-gaap:Depreciation>
  <us-gaap:SubsequentEventsTextBlock contextRef="cx_01_January_2014_TO_31_December_2014">&lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;
      &lt;b&gt;Note 12. Subsequent Events&lt;/b&gt;
    &lt;/p&gt;
    &lt;p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"&gt;The Company has implemented the most recent FASB accounting pronouncement for reporting subsequent events. This standard establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the consolidated financial statements are issued. The adoption of this accounting pronouncement did not impact our financial position or results of operations. The Company evaluated all events or transactions that occurred after December 31, 2014, up through the date these consolidated financial statements were issued and other than the disclosure in note 8 above, there were no subsequent events that occurred which required disclosure in the accompanying consolidated financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
